Substance_SID,Compound_CID,Data_Source,External_ID,Synonyms,Last_Modified_Date,Deposit_Date,Data_Source_Category,LTKBID,Compound Name,Severity Class,Label Section,vDILIConcern,Version
440791231,5732.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00164,zolpidem,20210312,20210312,Curation Efforts|Governmental Organizations,LT00164,zolpidem,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791230,60857.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01010,zolmitriptan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01010,zolmitriptan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791229,5311497.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00262,vinorelbine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00262,vinorelbine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791228,5665.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00969,vigabatrin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00969,vigabatrin,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791227,5362420.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01075,VERTEPORFIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01075,verteporfin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791226,135400189.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01135,Vardenafil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01135,vardenafil,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791225,135413535.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01109,Valganciclovir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01109,valganciclovir,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791224,6503.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00213,TROMETHAMINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00213,tromethamine,6.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791223,5584.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01844,trimipramine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01844,trimipramine,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791222,5577.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01841,trimethobenzamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01841,trimethobenzamide,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791221,5556.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01834,triazolam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01834,triazolam,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791220,33741.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01827,Tramadol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01827,tramadol,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791219,5505.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00453,tolbutamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00453,tolbutamide,2.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791218,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00973,Tinzaparin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00973,tinzaparin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791217,33624.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01815,timolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01815,timolol,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791216,60648.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00989,tiagabine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00989,tiagabine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791215,6018.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01239,TETRABENAZINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01239,tetrabenazine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791214,135409453.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00485,Tegaserod,20210312,20210312,Curation Efforts|Governmental Organizations,LT00485,tegaserod,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791213,110635.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01129,Tadalafil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01129,tadalafil,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791212,5358.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01779,sumatriptan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01779,sumatriptan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791211,15541.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01757,Spectinomycin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01757,spectinomycin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791210,5253.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00627,sotalol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00627,sotalol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791209,154059.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01191,Solifenacin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01191,solifenacin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791208,5312125.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00656,Silodosin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00656,silodosin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791207,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00463,Sacrosidase,20210312,20210312,Curation Efforts|Governmental Organizations,LT00463,sacrosidase,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791206,5245.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01020,Risedronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01020,risedronate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791205,6436173.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01128,Rifaximin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01128,rifaximin,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791204,37542.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01730,ribavirin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01730,ribavirin,7.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791203,3052776.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01204,rasagiline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01204,rasagiline,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791202,4911.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01698,probenecid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01698,probenecid,6.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791201,4893.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00435,prazosin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00435,prazosin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791200,119570.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00991,pramipexole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00991,pramipexole,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791199,135398747.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00610,pralidoxime,20210312,20210312,Curation Efforts|Governmental Organizations,LT00610,pralidoxime,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791198,4870.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01688,polythiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01688,polythiazide,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791197,5910.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01671,pilocarpine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01671,pilocarpine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791196,107807.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00955,PERINDOPRIL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00955,perindopril,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791195,47811.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00216,pergolide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00216,pergolide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791194,4740.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01652,pentoxifylline,20210312,20210312,Curation Efforts|Governmental Organizations,LT01652,pentoxifylline,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791193,37720.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00956,pentosan polysulfate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00956,pentosan polysulfate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791192,135410875.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01157,Pemetrexed,20231222,20210312,Curation Efforts|Governmental Organizations,LT01157,pemetrexed,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791191,5281104.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01015,Paricalcitol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01015,paricalcitol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791190,4674.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01916,pamidronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01916,pamidronate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791189,6337614.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01130,Palonosetron,20250421,20210312,Curation Efforts|Governmental Organizations,LT01130,palonosetron,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791188,4616.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00847,oxazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT00847,oxazepam,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791187,65028.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02210,oseltamivir,20231222,20210312,Curation Efforts|Governmental Organizations,LT02210,oseltamivir,3.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791186,158781.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01102,Olmesartan,20250421,20210312,Curation Efforts|Governmental Organizations,LT01102,olmesartan,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791185,6230.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00211,norethindrone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00211,norethindrone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791184,115355.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01092,Nitisinone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01092,nitisinone,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791183,4499.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00217,nisoldipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00217,nisoldipine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791182,4497.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01601,nimodipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01601,nimodipine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791181,4474.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01595,nicardipine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01595,nicardipine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791180,71301.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01212,Nebivolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01212,nebivolol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791179,5311309.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00594,nateglinide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00594,nateglinide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791178,4440.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01007,naratriptan,20250421,20210312,Curation Efforts|Governmental Organizations,LT01007,naratriptan,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791177,5388881.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01588,Nalmefene hydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT01588,nalmefene hydrochloride,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791176,39147.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01582,nadolol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01582,nadolol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791175,446541.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00310,mycophenolic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00310,mycophenolic acid,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791174,34633.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01571,MORICIZINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01571,moricizine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791173,91270.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01567,MOEXIPRIL,20231222,20210312,Curation Efforts|Governmental Organizations,LT01567,moexipril,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791172,5282381.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00922,misoprostol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00922,misoprostol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791171,4197.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00931,milrinone,20210804,20210312,Curation Efforts|Governmental Organizations,LT00931,milrinone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791170,62937.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00946,Metoprolol succinate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00946,metoprolol succinate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791169,4170.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02046,metolazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02046,metolazone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791168,4121.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00833,methyclothiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00833,methyclothiazide,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791167,9034.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00803,METHOHEXITAL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00803,methohexital,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791166,4107.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00581,methocarbamol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00581,methocarbamol,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791165,4095.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00723,methadone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00723,methadone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791164,4078.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01527,mesoridazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01527,mesoridazine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791163,23662354.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01526,mesna,20231222,20210312,Curation Efforts|Governmental Organizations,LT01526,mesna,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791162,4060.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01520,MEPHENYTOIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01520,mephenytoin,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791161,19090.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00220,megestrol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00220,megestrol,1.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791160,10631.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01513,medroxyprogesterone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01513,medroxyprogesterone,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791159,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01227,Mecasermin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01227,mecasermin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791158,16078.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00909,Marinol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00909,marinol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791157,4011.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01503,maprotiline,20250421,20210312,Curation Efforts|Governmental Organizations,LT01503,maprotiline,5.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791156,3964.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01501,loxapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01501,loxapine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791155,3948.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00574,lomefloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00574,lomefloxacin,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791154,11597698.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00571,Lisdexamfetamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00571,lisdexamfetamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791153,5961.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00482,L-glutamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00482,l-glutamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791152,118856773.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01013,Lepirudin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01013,lepirudin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791151,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02907,Laronidase,20210312,20210312,Curation Efforts|Governmental Organizations,LT02907,laronidase,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791150,71349.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00617,Lanreotide acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00617,lanreotide acetate,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791149,6445540.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02203,Ixabepilone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02203,ixabepilone,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791148,27661.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00340,isorbide mononitrate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00340,isorbide mononitrate,3.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791147,3702.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01444,indapamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01444,indapamide,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791146,71360.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00654,Iloperidone,20210804,20210312,Curation Efforts|Governmental Organizations,LT00654,iloperidone,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791145,70689311.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01258,HYDROXOCOBALAMIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01258,hydroxocobalamin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791144,5284570.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00919,hydromorphone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00919,hydromorphone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791143,3647.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00814,hydroflumethiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00814,hydroflumethiazide,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791142,25084151.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00426,Histrelin acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00426,histrelin acetate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791141,52919.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02427,HALOPERIDOL DECANOATE,20210804,20210312,Curation Efforts|Governmental Organizations,LT02427,haloperidol decanoate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791140,3520.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00708,guanidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00708,guanidine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791139,3519.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01422,GUANFACINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01422,guanfacine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791138,3510.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00557,granisetron,20231222,20210312,Curation Efforts|Governmental Organizations,LT00557,granisetron,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791137,5311128.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00939,goserelin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00939,goserelin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791136,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01419,Golimumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01419,golimumab,8.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791135,3081884.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00985,Glatiramer acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00985,glatiramer acetate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791134,135398740.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01406,ganciclovir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01406,ganciclovir,7.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791133,61635.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02064,Gallium nitrate,20250421,20210312,Curation Efforts|Governmental Organizations,LT02064,gallium nitrate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791132,9651.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01086,Galantamine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01086,galantamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791131,60754.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00951,gadodiamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00951,gadodiamide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791130,3440.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00299,furosemide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00299,furosemide,2.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791129,104741.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00401,Fulvestrant,20231222,20210312,Curation Efforts|Governmental Organizations,LT00401,fulvestrant,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791128,3415.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01397,foscarnet,20231222,20210312,Curation Efforts|Governmental Organizations,LT01397,foscarnet,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791127,135413538.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01257,Fosaprepitant,20231222,20210312,Curation Efforts|Governmental Organizations,LT01257,fosaprepitant,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791126,5324346.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01396,fluvoxamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01396,fluvoxamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791125,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01320,FILGRASTIM,20210312,20210312,Curation Efforts|Governmental Organizations,LT01320,filgrastim,1.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791124,3324.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00270,famciclovir,20250421,20210312,Curation Efforts|Governmental Organizations,LT00270,famciclovir,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791123,18477728.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01267,Everolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT01267,everolimus,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791122,3278.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01344,ETHACRYNIC ACID,20210312,20210312,Curation Efforts|Governmental Organizations,LT01344,ethacrynic acid,5.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791121,969472.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01161,Eszopiclone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01161,eszopiclone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791120,5284555.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00677,Estropipate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00677,estropipate,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791119,23676225.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02424,Estrogens  Conjugated,20231222,20210312,Curation Efforts|Governmental Organizations,,,,,,
440791118,5281037.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01001,Eprosartan,20210804,20210312,Curation Efforts|Governmental Organizations,LT01001,eprosartan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791117,5282411.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00971,epoprostenol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00971,epoprostenol,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791116,443872.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01149,Eplerenone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01149,eplerenone,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791115,5462501.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00381,Enalaprilat,20210312,20210312,Curation Efforts|Governmental Organizations,LT00381,enalaprilat,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791114,77993.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02024,Eletriptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT02024,eletriptan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791113,5281107.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00464,Doxercalciferol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00464,doxercalciferol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791112,3157.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01313,doxazosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01313,doxazosin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791111,73303.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00623,Doripenem,20231222,20210312,Curation Efforts|Governmental Organizations,LT00623,doripenem,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791110,3033818.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00986,dolasetron,20250421,20210312,Curation Efforts|Governmental Organizations,LT00986,dolasetron,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791109,3016.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00230,diazepam,20250421,20210312,Curation Efforts|Governmental Organizations,LT00230,diazepam,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791108,71384.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01273,Dexrazoxane,20250421,20210312,Curation Efforts|Governmental Organizations,LT01273,dexrazoxane,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791107,5311068.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01063,DEXMEDETOMIDINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01063,dexmedetomidine,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791106,5743.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00082,dexamethasone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00082,dexamethasone,3.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791105,5311065.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00896,DESMOPRESSIN,20250421,20210312,Curation Efforts|Governmental Organizations,LT00896,desmopressin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791104,2995.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01265,desipramine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01265,desipramine,3.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791103,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01347,Denileukin diftitox,20210312,20210312,Curation Efforts|Governmental Organizations,LT01347,denileukin diftitox,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791102,5625.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00996,Delavirdine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00996,delavirdine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791101,16136245.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00655,Degarelix,20250421,20210312,Curation Efforts|Governmental Organizations,LT00655,degarelix,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791100,451668.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00385,Decitabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00385,decitabine,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791099,6058.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01256,CYSTEAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01256,cysteamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791098,62816.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00881,COLESTIPOL,20250421,20210312,Curation Efforts|Governmental Organizations,LT00881,colestipol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791097,160051.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01080,Colesevelam,20250421,20210312,Curation Efforts|Governmental Organizations,LT01080,colesevelam,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791096,6167.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00076,colchicine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00076,colchicine,6.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791095,2803.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01231,clonidine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01231,clonidine,3.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791094,2754.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01025,cilostazol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01025,cilostazol,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791093,60613.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01216,Cidofovir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01216,cidofovir,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791092,70695641.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00328,Cholestyramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00328,cholestyramine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791091,2732.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01213,chlorthalidone,20250421,20210312,Curation Efforts|Governmental Organizations,LT01213,chlorthalidone,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791090,83898.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01048,Cevimeline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01048,cevimeline,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791089,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01412,Certolizumab pegol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01412,certolizumab pegol,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791088,38103.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01279,cephradine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01279,cephradine,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791087,6533629.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01281,ceftizoxime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01281,ceftizoxime,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791086,5282242.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01183,ceftibuten,20231222,20210312,Curation Efforts|Governmental Organizations,LT01183,ceftibuten,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791085,6335986.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01180,CEFPODOXIME,20231222,20210312,Curation Efforts|Governmental Organizations,LT01180,cefpodoxime,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791084,53025.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01178,cefotetan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01178,cefotetan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791083,5362065.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01173,CEFIXIME,20231222,20210312,Curation Efforts|Governmental Organizations,LT01173,cefixime,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791082,9870843.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01087,Cefditoren,20231222,20210312,Curation Efforts|Governmental Organizations,LT01087,cefditoren,2.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791081,135483770.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01889,capreomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01889,capreomycin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791080,2479.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00707,butabarbital,20231222,20210312,Curation Efforts|Governmental Organizations,LT00707,butabarbital,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791079,2477.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01148,buspirone,20210804,20210312,Curation Efforts|Governmental Organizations,LT01148,buspirone,3.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791078,2405.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01136,BISOPROLOL,20210312,20210312,Curation Efforts|Governmental Organizations,LT01136,bisoprolol,3.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791077,2369.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01132,betaxolol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01132,betaxolol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791076,54585.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00512,BALSALAZIDE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00512,balsalazide,8.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791075,5742832.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01110,aztreonam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01110,aztreonam,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791074,518740.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01093,arsenic trioxide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01093,arsenic trioxide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791073,60795.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01143,Aripiprazole,20210804,20210312,Curation Efforts|Governmental Organizations,LT01143,aripiprazole,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791072,146027575.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00962,APROTININ,20250421,20210312,Curation Efforts|Governmental Organizations,LT00962,aprotinin,7.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791071,135413536.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01195,Aprepitant,20210312,20210312,Curation Efforts|Governmental Organizations,LT01195,aprepitant,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791070,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01442,Antithymocyte globulin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01442,antithymocyte globulin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791069,3698.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01076,Amrinone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01076,amrinone,5.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791068,2170.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00256,amoxapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00256,amoxapine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791067,6918493.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00618,Ambrisentan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00618,ambrisentan,7.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791066,2123.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00502,altretamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00502,altretamine,2.0,Adverse reactions,Ambiguous DILI-concern,1.0
440791065,4775.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02343,4-PHENYLBUTYRIC ACID,20231222,20210312,Curation Efforts|Governmental Organizations,LT02343,4-phenylbutyric acid,4.0,Adverse reactions,Ambiguous DILI-concern,2.0
440791064,31401.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01855,URSODEOXYCHOLIC ACID,20231222,20210312,Curation Efforts|Governmental Organizations,LT01855,ursodeoxycholic acid,0.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791063,5583.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01843,trimetrexate,20210312,20210312,Curation Efforts|Governmental Organizations,LT01843,trimetrexate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791062,5576.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01840,trimethadione,20231222,20210312,Curation Efforts|Governmental Organizations,LT01840,trimethadione,5.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791061,5566.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00457,trifluoperazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00457,trifluoperazine,2.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791060,444795.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00338,tretinoin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00338,tretinoin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791059,3005573.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00158,toremifene,20210804,20210312,Curation Efforts|Governmental Organizations,LT00158,toremifene,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791058,41781.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00639,Torasemide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00639,torasemide,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791057,5483.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01818,tiopronin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01818,tiopronin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791056,54686904.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01222,Tigecycline,20210312,20210312,Curation Efforts|Governmental Organizations,LT01222,tigecycline,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791055,941651.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01805,thiothixene,20231222,20210312,Curation Efforts|Governmental Organizations,LT01805,thiothixene,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791054,5391.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01785,temazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01785,temazepam,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791053,159269.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00577,Telbivudine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00577,telbivudine,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791052,29327.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00628,streptozocin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00628,streptozocin,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791051,5193.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00624,secobarbital,20231222,20210312,Curation Efforts|Governmental Organizations,LT00624,secobarbital,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791050,129228.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00564,Rufinamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00564,rufinamide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791049,135403821.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01057,RIFAPENTINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01057,rifapentine,4.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791048,4946.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01706,propranolol,20250421,20210312,Curation Efforts|Governmental Organizations,LT01706,propranolol,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791047,4891.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00225,praziquantel,20210312,20210312,Curation Efforts|Governmental Organizations,LT00225,praziquantel,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791046,148121.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00673,Pralatrexate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00673,pralatrexate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791045,468595.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01254,Posaconazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT01254,posaconazole,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791044,5282452.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00668,Pitavastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00668,pitavastatin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791043,43672.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01675,piperacillin,20210804,20210312,Curation Efforts|Governmental Organizations,LT01675,piperacillin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791042,4737.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00130,pentobarbital,20231222,20210312,Curation Efforts|Governmental Organizations,LT00130,pentobarbital,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791041,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01069,Pegvisomant,20210312,20210312,Curation Efforts|Governmental Organizations,LT01069,pegvisomant,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791040,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01376,Peginterferon alfa-2a,20210312,20210312,Curation Efforts|Governmental Organizations,LT01376,peginterferon alfa-2a,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791039,54675779.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00605,oxytetracycline,20210312,20210312,Curation Efforts|Governmental Organizations,LT00605,oxytetracycline,2.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791038,644241.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00607,Nilotinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00607,nilotinib,4.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791037,5360515.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00311,naltrexone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00311,naltrexone,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791036,4421.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01587,nalidixic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01587,nalidixic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791035,4409.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01581,nabumetone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01581,nabumetone,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791034,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01326,Muromonab-CD3,20210312,20210312,Curation Efforts|Governmental Organizations,LT01326,muromonab-cd3,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791033,21945.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00322,Methenamine hippurate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00322,methenamine hippurate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791032,4037.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01511,meclofenamic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01511,meclofenamic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791031,4033.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01509,mechlorethamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01509,mechlorethamine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791030,3958.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00181,lorazepam,20210312,20210312,Curation Efforts|Governmental Organizations,LT00181,lorazepam,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791029,3000540.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01491,lincomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01491,lincomycin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791028,5862.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00933,L-cysteine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00933,l-cysteine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791027,219078.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00660,Lacosamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00660,lacosamide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791026,3759.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01469,isocarboxazid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01469,isocarboxazid,5.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791025,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01354,Interferon gamma-1b,20210312,20210312,Curation Efforts|Governmental Organizations,LT01354,interferon gamma-1b,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791024,5362440.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01446,indinavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01446,indinavir,8.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791023,42890.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01440,IDARUBICIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT01440,idarubicin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791022,169870.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00110,HYDROXYPROGESTERONE CAPROATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00110,hydroxyprogesterone caproate,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791021,131536.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01194,Fosamprenavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01194,fosamprenavir,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791020,3406.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00494,fomepizole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00494,fomepizole,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791019,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01953,Follitropin alfa/beta,20210312,20210312,Curation Efforts|Governmental Organizations,LT01953,follitropin alfa/beta,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791018,3394.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00298,flurbiprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00298,flurbiprofen,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440791017,3372.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00400,FLUPHENAZINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT00400,fluphenazine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791016,6446.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02031,fluoxymesterone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02031,fluoxymesterone,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791015,3366.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01381,flucytosine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01381,flucytosine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791014,64929.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00670,Fenofibric acid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00670,fenofibric acid,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791013,6917715.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01193,ETONOGESTREL,20231222,20210312,Curation Efforts|Governmental Organizations,LT01193,etonogestrel,5.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791012,3292.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00795,ethotoin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00795,ethotoin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791011,3291.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00831,ethosuximide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00831,ethosuximide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791010,5870.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02043,estrone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02043,estrone,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791009,150610.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01122,Ertapenem,20231222,20210312,Curation Efforts|Governmental Organizations,LT01122,ertapenem,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791008,41867.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00091,Epirubicin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00091,epirubicin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791007,135398508.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00538,Entecavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT00538,entecavir,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791006,24847866.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01169,Enfuvirtide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01169,enfuvirtide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791005,60877.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00515,Emtricitabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00515,emtricitabine,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791004,6049.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00760,Edetic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00760,edetic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791003,3108.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00294,dipyridamole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00294,dipyridamole,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791002,3019.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00865,diazoxide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00865,diazoxide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791001,54680690.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00081,demeclocycline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00081,demeclocycline,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440791000,6234.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01253,cycloserine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01253,cycloserine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790999,2809.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00341,clorazepate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00341,clorazepate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790998,119182.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01206,Clofarabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01206,clofarabine,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790997,443385.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02346,CLINDAMYCIN-2-PHOSPHATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02346,clindamycin-2-phosphate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790996,20279.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01224,Cladribine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01224,cladribine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790995,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01082,Choriogonadotropin alfa,20210312,20210312,Curation Efforts|Governmental Organizations,LT01082,choriogonadotropin alfa,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790994,10133.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00065,Chenodiol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00065,chenodiol,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790993,25074887.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00484,Cetrorelix,20231222,20210312,Curation Efforts|Governmental Organizations,LT00484,cetrorelix,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790992,441199.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01179,cefoxitin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01179,cefoxitin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790991,2826718.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01089,Caspofungin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01089,caspofungin,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790990,34359.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01160,carbidopa,20231222,20210312,Curation Efforts|Governmental Organizations,LT01160,carbidopa,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790989,60953.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02018,CAPECITABINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02018,capecitabine,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790988,2471.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01145,bumetanide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01145,bumetanide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790987,5360373.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01138,bleomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01138,bleomycin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790986,9444.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01028,Azacitidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01028,azacitidine,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790985,74989.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01096,ATOVAQUONE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01096,atovaquone,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790984,9690109.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01230,Armodafinil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01230,armodafinil,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790983,166548.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01203,Anidulafungin,20210804,20210312,Curation Efforts|Governmental Organizations,LT01203,anidulafungin,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790982,135409400.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00964,anagrelide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00964,anagrelide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790981,65016.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01055,amprenavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01055,amprenavir,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790980,2130.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00503,amantadine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00503,amantadine,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0
440790979,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01319,Aldesleukin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01319,aldesleukin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790978,1990.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00913,acetohydroxamic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00913,acetohydroxamic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0
440790977,5719.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00648,zaleplon,20210312,20210312,Curation Efforts|Governmental Organizations,LT00648,zaleplon,0.0,No match,vNo-DILI-Concern,2.0
440790976,5311.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00462,Vorinostat,20210312,20210312,Curation Efforts|Governmental Organizations,LT00462,vorinostat,0.0,No match,vNo-DILI-Concern,2.0
440790975,14985.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01516,VITAMIN E,20231222,20210312,Curation Efforts|Governmental Organizations,LT01516,vitamin e,0.0,No match,vNo-DILI-Concern,2.0
440790974,54670067.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02009,vitamin C,20231222,20210312,Curation Efforts|Governmental Organizations,LT02009,vitamin c,0.0,No match,vNo-DILI-Concern,2.0
440790973,13342.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00177,vinblastine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00177,vinblastine,0.0,No match,vNo-DILI-Concern,2.0
440790972,39765.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00916,Vecuronium,20210312,20210312,Curation Efforts|Governmental Organizations,LT00916,vecuronium,0.0,No match,vNo-DILI-Concern,2.0
440790971,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01416,Ustekinumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01416,ustekinumab,0.0,No match,vNo-DILI-Concern,2.0
440790970,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01229,Urokinase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01229,urokinase,0.0,No match,vNo-DILI-Concern,2.0
440790969,62819.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00929,Urofollitropin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00929,urofollitropin,0.0,No match,vNo-DILI-Concern,2.0
440790968,5610.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02356,tyramine,20250421,20210312,Curation Efforts|Governmental Organizations,LT02356,tyramine,0.0,No match,vNo-DILI-Concern,2.0
440790967,5284632.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00516,Trospium,20250421,20210312,Curation Efforts|Governmental Organizations,LT00516,trospium,0.0,No match,vNo-DILI-Concern,2.0
440790966,5282443.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00798,triprolidine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00798,triprolidine,0.0,No match,vNo-DILI-Concern,2.0
440790965,5572.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01839,trihexyphenidyl,20250421,20210312,Curation Efforts|Governmental Organizations,LT01839,trihexyphenidyl,0.0,No match,vNo-DILI-Concern,2.0
440790964,71433.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00375,Trientine hydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT00375,trientine hydrochloride,1.0,No match,vNo-DILI-Concern,2.0
440790963,5526.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00923,tranexamic acid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00923,tranexamic acid,0.0,No match,vNo-DILI-Concern,1.0
440790962,60700.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01824,topotecan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01824,topotecan,0.0,No match,vNo-DILI-Concern,2.0
440790961,443879.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01011,tolterodine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01011,tolterodine,0.0,No match,vNo-DILI-Concern,2.0
440790960,60947.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01037,tirofiban,20231222,20210312,Curation Efforts|Governmental Organizations,LT01037,tirofiban,0.0,No match,vNo-DILI-Concern,2.0
440790959,60937.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00998,Tiludronate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00998,tiludronate,0.0,No match,vNo-DILI-Concern,2.0
440790958,32281.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00751,Thyrotropin alfa,20231222,20210312,Curation Efforts|Governmental Organizations,LT00751,thyrotropin alfa,0.0,No match,vNo-DILI-Concern,2.0
440790957,1130.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01981,thiamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01981,thiamine,0.0,No match,vNo-DILI-Concern,2.0
440790956,2153.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00154,theophylline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00154,theophylline,0.0,No match,vNo-DILI-Concern,2.0
440790955,135402045.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01262,tetrahydrobiopterin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01262,tetrahydrobiopterin,0.0,No match,vNo-DILI-Concern,2.0
440790954,16133850.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00932,TERIPARATIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00932,teriparatide,0.0,No match,vNo-DILI-Concern,2.0
440790953,5401.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01787,terazosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01787,terazosin,0.0,No match,vNo-DILI-Concern,2.0
440790952,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01360,Tenecteplase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01360,tenecteplase,0.0,No match,vNo-DILI-Concern,2.0
440790951,18293306.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01261,Temsirolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT01261,temsirolimus,0.0,No match,vNo-DILI-Concern,2.0
440790950,9838022.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00664,Tapentadol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00664,tapentadol,0.0,No match,vNo-DILI-Concern,2.0
440790949,41693.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00920,SUFENTANIL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00920,sufentanil,0.0,No match,vNo-DILI-Concern,2.0
440790948,121494085.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00358,Sucralfate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00358,sucralfate,0.0,No match,vNo-DILI-Concern,2.0
440790947,5314.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00749,succinylcholine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00749,succinylcholine,0.0,No match,vNo-DILI-Concern,1.0
440790946,19649.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00145,streptomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00145,streptomycin,0.0,No match,vNo-DILI-Concern,1.0
440790945,962.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01294,Sterile water,20210312,20210312,Curation Efforts|Governmental Organizations,LT01294,sterile water,0.0,No match,vNo-DILI-Concern,2.0
440790944,5780.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02010,sorbitol,20250421,20210312,Curation Efforts|Governmental Organizations,LT02010,sorbitol,0.0,No match,vNo-DILI-Concern,2.0
440790943,16132356.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00888,Somatropin recombinant,20231222,20210312,Curation Efforts|Governmental Organizations,LT00888,somatropin recombinant,0.0,No match,vNo-DILI-Concern,2.0
440790942,24477.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00439,SODIUM THIOSULFATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00439,sodium thiosulfate,0.0,No match,vNo-DILI-Concern,2.0
440790941,75905.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00801,Sodium polystyrene sulfonate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00801,Sodium polystyrene sulfonate,0.0,No match,vNo-DILI-Concern,2.0
440790940,23666456.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00330,SODIUM LACTATE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00330,sodium lactate,0.0,No match,vNo-DILI-Concern,2.0
440790939,516892.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02337,SODIUM BICARBONATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02337,sodium bicarbonate,0.0,No match,vNo-DILI-Concern,2.0
440790938,9833444.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00350,Sincalide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00350,sincalide,0.0,No match,vNo-DILI-Concern,2.0
440790937,6433516.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02171,Simethicone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02171,simethicone,0.0,No match,vNo-DILI-Concern,2.0
440790936,3085017.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01039,Sevelamer,20250421,20210312,Curation Efforts|Governmental Organizations,LT01039,sevelamer,0.0,No match,vNo-DILI-Concern,2.0
440790935,26757.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01749,selegiline,20210312,20210312,Curation Efforts|Governmental Organizations,LT01749,selegiline,0.0,No match,vNo-DILI-Concern,2.0
440790934,16129665.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00355,SECRETIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00355,secretin,0.0,No match,vNo-DILI-Concern,2.0
440790933,5184.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01974,scopolamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01974,scopolamine,0.0,No match,vNo-DILI-Concern,2.0
440790932,11243969.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00667,Saxagliptin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00667,saxagliptin,0.0,No match,vNo-DILI-Concern,2.0
440790931,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01321,Sargramostim,20210312,20210312,Curation Efforts|Governmental Organizations,LT01321,sargramostim,0.0,No match,vNo-DILI-Concern,2.0
440790930,2083.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01051,Salbutamol,20250421,20210312,Curation Efforts|Governmental Organizations,LT01051,salbutamol,0.0,No match,vNo-DILI-Concern,1.0
440790929,71357.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00928,RUBIDIUM CHLORIDE RB-82,20231222,20210312,Curation Efforts|Governmental Organizations,LT00928,rubidium chloride rb-82,0.0,No match,vNo-DILI-Concern,2.0
440790928,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01417,Romiplostim,20210312,20210312,Curation Efforts|Governmental Organizations,LT01417,romiplostim,0.0,No match,vNo-DILI-Concern,2.0
440790927,5352062.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00669,Romidepsin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00669,romidepsin,0.0,No match,vNo-DILI-Concern,2.0
440790926,441290.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00957,Rocuronium,20250421,20210312,Curation Efforts|Governmental Organizations,LT00957,rocuronium,0.0,No match,vNo-DILI-Concern,2.0
440790925,5078.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01026,rizatriptan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01026,rizatriptan,0.0,No match,vNo-DILI-Concern,2.0
440790924,5071.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00937,rimantadine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00937,rimantadine,0.0,No match,vNo-DILI-Concern,2.0
440790923,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01415,Rilonacept,20210312,20210312,Curation Efforts|Governmental Organizations,LT01415,rilonacept,0.0,No match,vNo-DILI-Concern,2.0
440790922,493570.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01479,riboflavin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01479,riboflavin,0.0,No match,vNo-DILI-Concern,2.0
440790921,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01351,Reteplase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01351,reteplase,0.0,No match,vNo-DILI-Concern,2.0
440790920,5770.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01729,reserpine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01729,reserpine,0.0,No match,vNo-DILI-Concern,2.0
440790919,219024.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00646,Regadenoson,20231222,20210312,Curation Efforts|Governmental Organizations,LT00646,regadenoson,0.0,No match,vNo-DILI-Concern,2.0
440790918,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01363,rasburicase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01363,rasburicase,0.0,No match,vNo-DILI-Concern,2.0
440790917,56959.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01192,RANOLAZINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01192,ranolazine,0.0,No match,vNo-DILI-Concern,2.0
440790916,208902.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01217,Ramelteon,20231222,20210312,Curation Efforts|Governmental Organizations,LT01217,ramelteon,0.0,No match,vNo-DILI-Concern,2.0
440790915,5035.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00183,raloxifene,20231222,20210312,Curation Efforts|Governmental Organizations,LT00183,raloxifene,0.0,No match,vNo-DILI-Concern,2.0
440790914,4999.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01721,quazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01721,quazepam,0.0,No match,vNo-DILI-Concern,2.0
440790913,1054.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01980,pyridoxine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01980,pyridoxine,0.0,No match,vNo-DILI-Concern,2.0
440790912,4991.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02081,pyridostigmine,20210312,20210312,Curation Efforts|Governmental Organizations,LT02081,pyridostigmine,0.0,No match,vNo-DILI-Concern,2.0
440790911,708857.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01713,PYRANTEL,20231222,20210312,Curation Efforts|Governmental Organizations,LT01713,pyrantel,0.0,No match,vNo-DILI-Concern,2.0
440790910,7028.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00137,PSEUDOEPHEDRINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00137,pseudoephedrine,0.0,No match,vNo-DILI-Concern,2.0
440790909,4976.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00848,protriptyline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00848,protriptyline,0.0,No match,vNo-DILI-Concern,2.0
440790908,638678.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00349,protirelin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00349,protirelin,0.0,No match,vNo-DILI-Concern,2.0
440790907,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00728,Protamine sulfate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00728,protamine sulfate,0.0,No match,vNo-DILI-Concern,2.0
440790906,4934.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00753,propantheline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00753,propantheline,0.0,No match,vNo-DILI-Concern,2.0
440790905,4919.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02219,procyclidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02219,procyclidine,0.0,No match,vNo-DILI-Concern,1.0
440790904,4909.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00261,primidone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00261,primidone,0.0,No match,vNo-DILI-Concern,1.0
440790903,4908.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00613,PRIMAQUINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00613,primaquine,0.0,No match,vNo-DILI-Concern,1.0
440790902,16132446.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00492,Pramlintide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00492,pramlintide,0.0,No match,vNo-DILI-Concern,2.0
440790901,3086257.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00972,Porfimer,20231222,20210312,Curation Efforts|Governmental Organizations,LT00972,porfimer,0.0,No match,vNo-DILI-Concern,2.0
440790900,5702105.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01291,Polymyxin B sulfate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01291,polymyxin b sulfate,0.0,No match,vNo-DILI-Concern,2.0
440790899,174.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00995,Polyethylene glycol 3350,20231222,20210312,Curation Efforts|Governmental Organizations,LT00995,polyethylene glycol 3350,0.0,No match,vNo-DILI-Concern,2.0
440790898,65015.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02340,Plerixafor,20231222,20210312,Curation Efforts|Governmental Organizations,LT02340,plerixafor,0.0,No match,vNo-DILI-Concern,2.0
440790897,4828.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01673,pindolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01673,pindolol,0.0,No match,vNo-DILI-Concern,2.0
440790896,16362.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01672,pimozide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01672,pimozide,0.0,No match,vNo-DILI-Concern,2.0
440790895,5284607.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00780,phytonadione,20231222,20210312,Curation Efforts|Governmental Organizations,LT00780,phytonadione,0.0,No match,vNo-DILI-Concern,2.0
440790894,5983.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00133,physostigmine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00133,physostigmine,0.0,No match,vNo-DILI-Concern,2.0
440790893,5775.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00433,phentolamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00433,phentolamine,0.0,No match,vNo-DILI-Concern,1.0
440790892,4768.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02082,phenoxybenzamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT02082,phenoxybenzamine,0.0,No match,vNo-DILI-Concern,1.0
440790891,30487.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00826,phendimetrazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00826,phendimetrazine,0.0,No match,vNo-DILI-Concern,1.0
440790890,6432.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01065,Perflutren,20231222,20210312,Curation Efforts|Governmental Organizations,LT01065,perflutren,0.0,No match,vNo-DILI-Concern,2.0
440790889,3053.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00879,Pentetic acid,20210804,20210312,Curation Efforts|Governmental Organizations,LT00879,pentetic acid,0.0,No match,vNo-DILI-Concern,2.0
440790888,441278.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01650,pentazocine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01650,pentazocine,0.0,No match,vNo-DILI-Concern,2.0
440790887,9853654.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00869,pentagastrin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00869,pentagastrin,0.0,No match,vNo-DILI-Concern,2.0
440790886,6869.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01648,penicillin v,20231222,20210312,Curation Efforts|Governmental Organizations,LT01648,penicillin v,0.0,No match,vNo-DILI-Concern,2.0
440790885,37464.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01644,penbutolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01644,penbutolol,0.0,No match,vNo-DILI-Concern,1.0
440790884,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01380,Pegfilgrastim,20210312,20210312,Curation Efforts|Governmental Organizations,LT01380,pegfilgrastim,0.0,No match,vNo-DILI-Concern,2.0
440790883,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00941,Pegademase bovine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00941,pegademase bovine,0.0,No match,vNo-DILI-Concern,2.0
440790882,165580.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02061,paromomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02061,paromomycin,0.0,No match,vNo-DILI-Concern,1.0
440790881,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01408,Panitumumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01408,panitumumab,0.0,No match,vNo-DILI-Concern,2.0
440790880,441289.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00867,pancuronium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00867,pancuronium,0.0,No match,vNo-DILI-Concern,2.0
440790879,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00674,Pancrelipase,20210312,20210312,Curation Efforts|Governmental Organizations,LT00674,pancrelipase,0.0,No match,vNo-DILI-Concern,2.0
440790878,11806.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02055,PAMABROM,20231222,20210312,Curation Efforts|Governmental Organizations,LT02055,pamabrom,0.0,No match,vNo-DILI-Concern,2.0
440790877,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01349,Palivizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01349,palivizumab,0.0,No match,vNo-DILI-Concern,2.0
440790876,115237.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01252,Paliperidone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01252,paliperidone,0.0,No match,vNo-DILI-Concern,2.0
440790875,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01392,Palifermin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01392,palifermin,0.0,No match,vNo-DILI-Concern,2.0
440790874,439302.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00827,OXYTOCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00827,oxytocin,0.0,No match,vNo-DILI-Concern,2.0
440790873,5284604.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00808,oxymorphone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00808,oxymorphone,0.0,No match,vNo-DILI-Concern,2.0
440790872,5284603.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00979,oxycodone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00979,oxycodone,0.0,No match,vNo-DILI-Concern,2.0
440790871,4634.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02084,oxybutynin,20250421,20210312,Curation Efforts|Governmental Organizations,LT02084,oxybutynin,0.0,No match,vNo-DILI-Concern,1.0
440790870,4601.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02085,orphenadrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02085,orphenadrine,0.0,No match,vNo-DILI-Concern,2.0
440790869,4086.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02086,ORCIPRENALINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT02086,orciprenaline,0.0,No match,vNo-DILI-Concern,1.0
440790868,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01339,Oprelvekin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01339,oprelvekin,0.0,No match,vNo-DILI-Concern,2.0
440790867,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01377,Omalizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01377,omalizumab,0.0,No match,vNo-DILI-Concern,2.0
440790866,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01421,Ofatumumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01421,ofatumumab,0.0,No match,vNo-DILI-Concern,2.0
440790865,11286230.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00602,nystatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00602,nystatin,0.0,No match,vNo-DILI-Concern,1.0
440790864,5832.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02269,Norethindrone acetate,20210312,20210312,Curation Efforts|Governmental Organizations,LT02269,norethindrone acetate,0.0,No match,vNo-DILI-Concern,2.0
440790863,439260.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00738,norepinephrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00738,norepinephrine,0.0,No match,vNo-DILI-Concern,1.0
440790862,11953895.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00880,Nitroprusside,20231222,20210312,Curation Efforts|Governmental Organizations,LT00880,nitroprusside,0.0,No match,vNo-DILI-Concern,2.0
440790861,4510.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01608,nitroglycerin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01608,nitroglycerin,0.0,No match,vNo-DILI-Concern,2.0
440790860,41684.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01184,NITAZOXANIDE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01184,nitazoxanide,0.0,No match,vNo-DILI-Concern,2.0
440790859,25081014.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00465,Nesiritide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00465,nesiritide,0.0,No match,vNo-DILI-Concern,2.0
440790858,8378.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00595,neomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00595,neomycin,0.0,No match,vNo-DILI-Concern,1.0
440790857,5284596.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00592,naloxone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00592,naloxone,0.0,No match,vNo-DILI-Concern,2.0
440790856,5311304.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01586,nalbuphine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01586,nalbuphine,0.0,No match,vNo-DILI-Concern,2.0
440790855,5284592.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00910,Nabilone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00910,nabilone,0.0,No match,vNo-DILI-Concern,2.0
440790854,5288826.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00905,morphine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00905,morphine,0.0,No match,vNo-DILI-Concern,2.0
440790853,5281042.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00950,Mivacurium,20250421,20210312,Curation Efforts|Governmental Organizations,LT00950,mivacurium,0.0,No match,vNo-DILI-Concern,2.0
440790852,4211.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01564,mitotane,20231222,20210312,Curation Efforts|Governmental Organizations,LT01564,mitotane,0.0,No match,vNo-DILI-Concern,2.0
440790851,4201.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00587,minoxidil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00587,minoxidil,0.0,No match,vNo-DILI-Concern,1.0
440790850,51634.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01126,Miglustat,20231222,20210312,Curation Efforts|Governmental Organizations,LT01126,miglustat,0.0,No match,vNo-DILI-Concern,2.0
440790849,441314.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00992,MIGLITOL,20210312,20210312,Curation Efforts|Governmental Organizations,LT00992,miglitol,0.0,No match,vNo-DILI-Concern,2.0
440790848,55245.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00184,mifepristone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00184,mifepristone,0.0,No match,vNo-DILI-Concern,2.0
440790847,4195.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01558,midodrine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01558,midodrine,0.0,No match,vNo-DILI-Concern,2.0
440790846,4192.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01557,midazolam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01557,midazolam,0.0,No match,vNo-DILI-Concern,2.0
440790845,441350.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00895,METYROSINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00895,metyrosine,0.0,No match,vNo-DILI-Concern,1.0
440790844,4174.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00838,metyrapone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00838,metyrapone,0.0,No match,vNo-DILI-Concern,1.0
440790843,9681.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02072,methysergide,20210312,20210312,Curation Efforts|Governmental Organizations,LT02072,methysergide,0.0,No match,vNo-DILI-Concern,1.0
440790842,23724781.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01547,Methylscopolamine bromide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01547,methylscopolamine bromide,0.0,No match,vNo-DILI-Concern,2.0
440790841,5361917.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00570,Methylnaltrexone bromide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00570,methylnaltrexone bromide,0.0,No match,vNo-DILI-Concern,2.0
440790840,8226.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02074,methylergonovine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02074,methylergonovine,0.0,No match,vNo-DILI-Concern,2.0
440790839,6476.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00787,METHSUXIMIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00787,methsuximide,0.0,No match,vNo-DILI-Concern,2.0
440790838,10836.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00716,METHAMPHETAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00716,methamphetamine,0.0,No match,vNo-DILI-Concern,2.0
440790837,4064.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01521,meprobamate,20210312,20210312,Curation Efforts|Governmental Organizations,LT01521,meprobamate,0.0,No match,vNo-DILI-Concern,2.0
440790836,4062.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00822,mepivacaine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00822,mepivacaine,0.0,No match,vNo-DILI-Concern,2.0
440790835,4058.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00713,meperidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00713,meperidine,0.0,No match,vNo-DILI-Concern,2.0
440790834,4057.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00790,mepenzolate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00790,mepenzolate,0.0,No match,vNo-DILI-Concern,2.0
440790833,4034.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00792,meclizine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00792,meclizine,0.0,No match,vNo-DILI-Concern,1.0
440790832,4032.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00781,mecamylamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00781,mecamylamine,0.0,No match,vNo-DILI-Concern,2.0
440790831,6251.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00024,mannitol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00024,mannitol,0.0,No match,vNo-DILI-Concern,1.0
440790830,157920.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01240,Lubiprostone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01240,lubiprostone,0.0,No match,vNo-DILI-Concern,2.0
440790829,3957.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01498,loratadine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01498,loratadine,0.0,No match,vNo-DILI-Concern,2.0
440790828,3955.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02087,loperamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT02087,loperamide,0.0,No match,vNo-DILI-Concern,2.0
440790827,6137.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01468,L-methionine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01468,l-methionine,0.0,No match,vNo-DILI-Concern,2.0
440790826,5920.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00783,liothyronine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00783,liothyronine,0.0,No match,vNo-DILI-Concern,1.0
440790825,3676.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01905,lidocaine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01905,lidocaine,0.0,No match,vNo-DILI-Concern,2.0
440790824,5359272.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00752,levorphanol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00752,levorphanol,0.0,No match,vNo-DILI-Concern,2.0
440790823,13109.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01489,Levonorgestrel,20210312,20210312,Curation Efforts|Governmental Organizations,LT01489,levonorgestrel,0.0,No match,vNo-DILI-Concern,2.0
440790822,135564391.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02442,Levomefolate calcium,20250421,20210312,Curation Efforts|Governmental Organizations,LT02442,levomefolate calcium,0.0,No match,vNo-DILI-Concern,2.0
440790821,135398559.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02437,Levoleucovorin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02437,Levoleucovorin,0.0,No match,vNo-DILI-Concern,2.0
440790820,135403648.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02192,leucovorin,20250421,20210312,Curation Efforts|Governmental Organizations,LT02192,leucovorin,0.0,No match,vNo-DILI-Concern,2.0
440790819,10917.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01486,L-carnitine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01486,l-carnitine,0.0,No match,vNo-DILI-Concern,1.0
440790818,6322.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02077,L-arginine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02077,l-arginine,0.0,No match,vNo-DILI-Concern,2.0
440790817,168924.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00493,Lanthanum Carbonate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00493,lanthanum carbonate,0.0,No match,vNo-DILI-Concern,2.0
440790816,11333.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00886,lactulose,20231222,20210312,Curation Efforts|Governmental Organizations,LT00886,lactulose,0.0,No match,vNo-DILI-Concern,1.0
440790815,6032.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01477,kanamycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01477,kanamycin,0.0,No match,vNo-DILI-Concern,1.0
440790814,3783.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02089,isoxsuprine,20250421,20210312,Curation Efforts|Governmental Organizations,LT02089,isoxsuprine,0.0,No match,vNo-DILI-Concern,2.0
440790813,6883.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00818,ISOSORBIDE DINITRATE,20210804,20210312,Curation Efforts|Governmental Organizations,LT00818,isosorbide dinitrate,0.0,No match,vNo-DILI-Concern,2.0
440790812,3779.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00200,isoproterenol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00200,isoproterenol,0.0,No match,vNo-DILI-Concern,1.0
440790811,3741.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00419,ioversol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00419,ioversol,0.0,No match,vNo-DILI-Concern,2.0
440790810,23667529.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00257,Iothalamate sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00257,iothalamate sodium,0.0,No match,vNo-DILI-Concern,2.0
440790809,3739.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01454,IODIPAMIDE MEGLUMINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01454,iodipamide meglumine,0.0,No match,vNo-DILI-Concern,2.0
440790808,11967809.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00141,indocyanine green,20231222,20210312,Curation Efforts|Governmental Organizations,LT00141,indocyanine green,0.0,No match,vNo-DILI-Concern,2.0
440790807,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02384,Imiglucerase,20210312,20210312,Curation Efforts|Governmental Organizations,LT02384,imiglucerase,0.0,No match,vNo-DILI-Concern,2.0
440790806,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01409,Idursulfase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01409,idursulfase,0.0,No match,vNo-DILI-Concern,2.0
440790805,60753.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00974,Ibutilide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00974,ibutilide,0.0,No match,vNo-DILI-Concern,2.0
440790804,92002593.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01378,Ibritumomab tiuxetan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01378,ibritumomab tiuxetan,0.0,No match,vNo-DILI-Concern,2.0
440790803,60852.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01156,Ibandronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01156,ibandronate,0.0,No match,vNo-DILI-Concern,2.0
440790802,3658.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01437,hydroxyzine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01437,hydroxyzine,0.0,No match,vNo-DILI-Concern,1.0
440790801,5754.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00188,hydrocortisone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00188,hydrocortisone,0.0,No match,vNo-DILI-Concern,2.0
440790800,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02913,Hyaluronidase recombinant human,20210312,20210312,Curation Efforts|Governmental Organizations,LT02913,hyaluronidase recombinant human,0.0,No match,vNo-DILI-Concern,2.0
440790799,91820602.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00725,Hyaluronidase,20231222,20210312,Curation Efforts|Governmental Organizations,LT00725,hyaluronidase,0.0,No match,vNo-DILI-Concern,2.0
440790798,65513.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00706,Histamine diphosphate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00706,histamine diphosphate,0.0,No match,vNo-DILI-Concern,2.0
440790797,24846132.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02382,Hetastarch,20231222,20210312,Curation Efforts|Governmental Organizations,LT02382,Hetastarch,0.0,No match,vNo-DILI-Concern,2.0
440790796,3518.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00829,GUANETHIDINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00829,guanethidine,0.0,No match,vNo-DILI-Concern,1.0
440790795,3516.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01100,guaifenesin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01100,guaifenesin,0.0,No match,vNo-DILI-Concern,2.0
440790794,11693.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00836,GLYCOPYRROLATE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00836,glycopyrrolate,0.0,No match,vNo-DILI-Concern,2.0
440790793,23724914.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00475,Ganirelix acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00475,ganirelix acetate,0.0,No match,vNo-DILI-Concern,2.0
440790792,10413.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00480,Gamma Hydroxybutyric Acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00480,gamma hydroxybutyric acid,0.0,No match,vNo-DILI-Concern,2.0
440790791,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01401,Galsulfase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01401,galsulfase,0.0,No match,vNo-DILI-Concern,2.0
440790790,444013.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01044,GADOVERSETAMIDE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01044,gadoversetamide,0.0,No match,vNo-DILI-Concern,2.0
440790789,60714.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00952,GADOTERIDOL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00952,gadoteridol,0.0,No match,vNo-DILI-Concern,2.0
440790788,55466.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00935,GADOPENTETATE DIMEGLUMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00935,gadopentetate dimeglumine,0.0,No match,vNo-DILI-Concern,2.0
440790787,91754427.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02404,Gadolinium Ethoxybenzyl Dtpa,20231222,20210312,Curation Efforts|Governmental Organizations,LT02404,gadolinium ethoxybenzyl DTPA,0.0,No match,vNo-DILI-Concern,2.0
440790786,73049652.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00528,Gadofosveset trisodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00528,gadofosveset trisodium,0.0,No match,vNo-DILI-Concern,2.0
440790785,6918204.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01127,Gadobenate dimeglumine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01127,gadobenate dimeglumine,0.0,No match,vNo-DILI-Concern,2.0
440790784,77992.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01054,Frovatriptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01054,frovatriptan,0.0,No match,vNo-DILI-Concern,2.0
440790783,135398658.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01580,folic acid,20250421,20210312,Curation Efforts|Governmental Organizations,LT01580,folic acid,0.0,No match,vNo-DILI-Concern,1.0
440790782,16850.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00894,fluorescein,20210804,20210312,Curation Efforts|Governmental Organizations,LT00894,fluorescein,0.0,No match,vNo-DILI-Concern,2.0
440790781,3373.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01384,flumazenil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01384,flumazenil,0.0,No match,vNo-DILI-Concern,2.0
440790780,31378.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00399,fludrocortisone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00399,fludrocortisone,0.0,No match,vNo-DILI-Concern,2.0
440790779,657237.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01382,Fludarabine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01382,fludarabine,0.0,No match,vNo-DILI-Concern,2.0
440790778,3354.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00857,flavoxate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00857,flavoxate,0.0,No match,vNo-DILI-Concern,1.0
440790777,3348.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01370,fexofenadine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01370,fexofenadine,0.0,No match,vNo-DILI-Concern,2.0
440790776,6918558.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00590,Fesoterodine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00590,fesoterodine,0.0,No match,vNo-DILI-Concern,2.0
440790775,14789.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00650,Ferumoxytol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00650,ferumoxytol,0.0,No match,vNo-DILI-Concern,2.0
440790774,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00966,Ferumoxsil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00966,ferumoxsil,0.0,No match,vNo-DILI-Concern,2.0
440790773,6432052.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00967,Ferumoxides,20231222,20210312,Curation Efforts|Governmental Organizations,LT00967,ferumoxides,0.0,No match,vNo-DILI-Concern,2.0
440790772,3341.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00944,fenoldopam,20210312,20210312,Curation Efforts|Governmental Organizations,LT00944,fenoldopam,0.0,No match,vNo-DILI-Concern,2.0
440790771,45588096.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00537,Exenatide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00537,exenatide,0.0,No match,vNo-DILI-Concern,2.0
440790770,9552071.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02329,Exametazime,20231222,20210312,Curation Efforts|Governmental Organizations,LT02329,exametazime,0.0,No match,vNo-DILI-Concern,2.0
440790769,667484.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01357,Etomidate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01357,etomidate,0.0,No match,vNo-DILI-Concern,2.0
440790768,3305.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01355,Etidronic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT01355,etidronic acid,0.0,No match,vNo-DILI-Concern,1.0
440790767,5282489.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00926,ETHANOLAMINE OLEATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00926,ethanolamine oleate,0.0,No match,vNo-DILI-Concern,1.0
440790766,3261.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01334,estazolam,20210804,20210312,Curation Efforts|Governmental Organizations,LT01334,estazolam,0.0,No match,vNo-DILI-Concern,2.0
440790765,59768.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01333,ESMOLOL,20210312,20210312,Curation Efforts|Governmental Organizations,LT01333,esmolol,0.0,No match,vNo-DILI-Concern,1.0
440790764,11751549.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02330,ERYTHROPOIETIN,20250421,20210312,Curation Efforts|Governmental Organizations,LT02330,erythropoietin,0.0,No match,vNo-DILI-Concern,2.0
440790763,5280793.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00194,ergocalciferol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00194,ergocalciferol,0.0,No match,vNo-DILI-Concern,1.0
440790762,448812.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00999,Eptifibatide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00999,eptifibatide,0.0,No match,vNo-DILI-Concern,2.0
440790761,127893.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01316,EPOETIN ALFA,20231222,20210312,Curation Efforts|Governmental Organizations,LT01316,epoetin alfa,0.0,No match,vNo-DILI-Concern,2.0
440790760,5816.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00742,epinephrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00742,epinephrine,0.0,No match,vNo-DILI-Concern,1.0
440790759,9294.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01666,Ephedrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01666,ephedrine,0.0,No match,vNo-DILI-Concern,2.0
440790758,3202.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02093,edrophonium,20210312,20210312,Curation Efforts|Governmental Organizations,LT02093,edrophonium,0.0,No match,vNo-DILI-Concern,1.0
440790757,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01414,Eculizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01414,eculizumab,0.0,No match,vNo-DILI-Concern,2.0
440790756,44152182.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00683,Ecallantide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00683,ecallantide,0.0,No match,vNo-DILI-Concern,2.0
440790755,3182.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00740,dyphylline,20250421,20210312,Curation Efforts|Governmental Organizations,LT00740,dyphylline,0.0,No match,vNo-DILI-Concern,2.0
440790754,6918296.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01112,Dutasteride,20231222,20210312,Curation Efforts|Governmental Organizations,LT01112,dutasteride,0.0,No match,vNo-DILI-Concern,2.0
440790753,3168.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01317,droperidol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01317,droperidol,0.0,No match,vNo-DILI-Concern,2.0
440790752,3162.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00727,doxylamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00727,doxylamine,0.0,No match,vNo-DILI-Concern,2.0
440790751,3156.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00547,doxapram,20250421,20210312,Curation Efforts|Governmental Organizations,LT00547,doxapram,0.0,No match,vNo-DILI-Concern,2.0
440790750,681.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00015,dopamine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00015,dopamine,0.0,No match,vNo-DILI-Concern,2.0
440790749,71329.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01040,Dofetilide,20210804,20210312,Curation Efforts|Governmental Organizations,LT01040,dofetilide,0.0,No match,vNo-DILI-Concern,2.0
440790748,36811.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01308,dobutamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01308,dobutamine,0.0,No match,vNo-DILI-Concern,1.0
440790747,13505.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01623,DIPHENOXYLATE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01623,diphenoxylate,0.0,No match,vNo-DILI-Concern,2.0
440790746,3100.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00087,diphenhydramine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00087,diphenhydramine,0.0,No match,vNo-DILI-Concern,1.0
440790745,3080.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00074,DIMERCAPROL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00074,dimercaprol,0.0,No match,vNo-DILI-Concern,2.0
440790744,10660.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00545,DIMENHYDRINATE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00545,dimenhydrinate,0.0,No match,vNo-DILI-Concern,2.0
440790743,10531.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02218,dihydroergotamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02218,dihydroergotamine,0.0,No match,vNo-DILI-Concern,1.0
440790742,2724385.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00292,digoxin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00292,digoxin,0.0,No match,vNo-DILI-Concern,1.0
440790741,7029.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00806,DIETHYLPROPION,20231222,20210312,Curation Efforts|Governmental Organizations,LT00806,diethylpropion,0.0,No match,vNo-DILI-Concern,2.0
440790740,3042.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00737,dicyclomine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00737,dicyclomine,0.0,No match,vNo-DILI-Concern,2.0
440790739,3038.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00802,dichlorphenamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00802,dichlorphenamide,0.0,No match,vNo-DILI-Concern,2.0
440790738,2140.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00774,DIATRIZOATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00774,diatrizoate,0.0,No match,vNo-DILI-Concern,2.0
440790737,5793.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00327,dextrose,20231222,20210312,Curation Efforts|Governmental Organizations,LT00327,dextrose,0.0,No match,vNo-DILI-Concern,2.0
440790736,5360696.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02056,dextromethorphan,20231222,20210312,Curation Efforts|Governmental Organizations,LT02056,dextromethorphan,0.0,No match,vNo-DILI-Concern,2.0
440790735,5826.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00870,dextroamphetamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00870,dextroamphetamine,0.0,No match,vNo-DILI-Concern,2.0
440790734,131204.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01972,Dexpanthenol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01972,dexpanthenol,0.0,No match,vNo-DILI-Concern,2.0
440790733,33036.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00682,DEXCHLORPHENIRAMINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00682,dexchlorpheniramine,0.0,No match,vNo-DILI-Concern,2.0
440790732,16960.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00810,Dexbrompheniramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00810,dexbrompheniramine,0.0,No match,vNo-DILI-Concern,2.0
440790731,30323.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00540,daunorubicin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00540,daunorubicin,0.0,No match,vNo-DILI-Concern,2.0
440790730,444031.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01188,Darifenacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01188,darifenacin,0.0,No match,vNo-DILI-Concern,2.0
440790729,5311498.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02002,cyanocobalamin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02002,cyanocobalamin,0.0,No match,vNo-DILI-Concern,1.0
440790728,24014.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00361,CUPRIC CHLORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00361,cupric chloride,0.0,No match,vNo-DILI-Concern,2.0
440790727,16129617.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00855,COSYNTROPIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00855,cosyntropin,0.0,No match,vNo-DILI-Concern,2.0
440790726,5745.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00734,CORTISONE ACETATE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00734,cortisone acetate,0.0,No match,vNo-DILI-Concern,2.0
440790725,16132265.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00077,corticotropin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00077,corticotropin,0.0,No match,vNo-DILI-Concern,2.0
440790724,16132344.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00438,Corticorelin ovine triflutate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00438,corticorelin ovine triflutate,0.0,No match,vNo-DILI-Concern,2.0
440790723,151171.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01210,Conivaptan,20250421,20210312,Curation Efforts|Governmental Organizations,LT01210,conivaptan,0.0,No match,vNo-DILI-Concern,2.0
440790722,216258.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01275,Colistimethate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01275,colistimethate,0.0,No match,vNo-DILI-Concern,1.0
440790721,5284371.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01269,codeine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01269,codeine,0.0,No match,vNo-DILI-Concern,2.0
440790720,153994.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00644,Clevidipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00644,clevidipine,0.0,No match,vNo-DILI-Concern,2.0
440790719,26987.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02222,clemastine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02222,clemastine,0.0,No match,vNo-DILI-Concern,1.0
440790718,62886.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00978,Cisatracurium besylate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00978,cisatracurium besylate,0.0,No match,vNo-DILI-Concern,2.0
440790717,156419.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01209,Cinacalcet,20231222,20210312,Curation Efforts|Governmental Organizations,LT01209,cinacalcet,0.0,No match,vNo-DILI-Concern,2.0
440790716,2725.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00009,chlorpheniramine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00009,chlorpheniramine,0.0,No match,vNo-DILI-Concern,2.0
440790715,5959.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01196,chloramphenicol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01196,chloramphenicol,0.0,No match,vNo-DILI-Concern,2.0
440790714,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01389,Cetuximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01389,cetuximab,0.0,No match,vNo-DILI-Concern,2.0
440790713,2576.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02037,carisoprodol,20210312,20210312,Curation Efforts|Governmental Organizations,LT02037,carisoprodol,0.0,No match,vNo-DILI-Concern,2.0
440790712,5281074.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00898,CARBOPROST TROMETHAMINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00898,carboprost tromethamine,0.0,No match,vNo-DILI-Concern,2.0
440790711,2564.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00759,carbinoxamine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00759,carbinoxamine,0.0,No match,vNo-DILI-Concern,1.0
440790710,6116.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00947,Calcium acetate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00947,calcium acetate,0.0,No match,vNo-DILI-Concern,2.0
440790709,5280453.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00899,calcitriol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00899,calcitriol,0.0,No match,vNo-DILI-Concern,2.0
440790708,16133812.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00878,Calcitonin salmon,20231222,20210312,Curation Efforts|Governmental Organizations,LT00878,calcitonin salmon,0.0,No match,vNo-DILI-Concern,2.0
440790707,2519.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01888,caffeine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01888,caffeine,0.0,No match,vNo-DILI-Concern,2.0
440790706,54746.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01152,cabergoline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01152,cabergoline,0.0,No match,vNo-DILI-Concern,2.0
440790705,5361092.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01151,butorphanol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01151,butorphanol,0.0,No match,vNo-DILI-Concern,2.0
440790704,5281004.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01144,budesonide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01144,budesonide,0.0,No match,vNo-DILI-Concern,2.0
440790703,6834.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02076,BROMPHENIRAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02076,brompheniramine,0.0,No match,vNo-DILI-Concern,2.0
440790702,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01356,Botulinum toxin type B,20210312,20210312,Curation Efforts|Governmental Organizations,LT01356,botulinum toxin type b,0.0,No match,vNo-DILI-Concern,2.0
440790701,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01305,Botulinum toxin type A,20210312,20210312,Curation Efforts|Governmental Organizations,LT01305,botulinum toxin type a,0.0,No match,vNo-DILI-Concern,2.0
440790700,16129704.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01027,Bivalirudin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01027,bivalirudin,0.0,No match,vNo-DILI-Concern,2.0
440790699,2391.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02190,bisacodyl,20250421,20210312,Curation Efforts|Governmental Organizations,LT02190,bisacodyl,0.0,No match,vNo-DILI-Concern,2.0
440790698,2381.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00817,biperiden,20250421,20210312,Curation Efforts|Governmental Organizations,LT00817,biperiden,0.0,No match,vNo-DILI-Concern,1.0
440790697,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01390,Bevacizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01390,bevacizumab,0.0,No match,vNo-DILI-Concern,2.0
440790696,2370.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00730,bethanechol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00730,bethanechol,0.0,No match,vNo-DILI-Concern,1.0
440790695,247.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02189,betaine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02189,betaine,0.0,No match,vNo-DILI-Concern,1.0
440790694,45266800.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01276,Benzylpenicilloyl polylysine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01276,benzylpenicilloyl polylysine,0.0,No match,vNo-DILI-Concern,2.0
440790693,1201549.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01123,benztropine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01123,benztropine,0.0,No match,vNo-DILI-Concern,1.0
440790692,5311017.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00832,benzphetamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00832,benzphetamine,0.0,No match,vNo-DILI-Concern,1.0
440790691,65628.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00659,Bendamustine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00659,bendamustine,0.0,No match,vNo-DILI-Concern,2.0
440790690,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01346,Basiliximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01346,basiliximab,0.0,No match,vNo-DILI-Concern,2.0
440790689,439542.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02059,bacitracin,20210312,20210312,Curation Efforts|Governmental Organizations,LT02059,bacitracin,0.0,No match,vNo-DILI-Concern,1.0
440790688,174174.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00511,ATROPINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00511,atropine,0.0,No match,vNo-DILI-Concern,1.0
440790687,47319.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00917,Atracurium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00917,atracurium,0.0,No match,vNo-DILI-Concern,1.0
440790686,8230.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02331,ARGIPRESSIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT02331,Argipressin,0.0,No match,vNo-DILI-Concern,2.0
440790685,92722.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01030,argatroban,20210312,20210312,Curation Efforts|Governmental Organizations,LT01030,argatroban,0.0,No match,vNo-DILI-Concern,2.0
440790684,6005.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02217,apomorphine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02217,apomorphine,0.0,No match,vNo-DILI-Concern,2.0
440790683,25517.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02067,AMMONIUM CHLORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02067,ammonium chloride,0.0,No match,vNo-DILI-Concern,2.0
440790682,9433.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00711,aminophylline,20250421,20210312,Curation Efforts|Governmental Organizations,LT00711,aminophylline,0.0,No match,vNo-DILI-Concern,2.0
440790681,2148.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00054,Aminohippurate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00054,aminohippurate,0.0,No match,vNo-DILI-Concern,2.0
440790680,564.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01071,aminocaproic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT01071,aminocaproic acid,0.0,No match,vNo-DILI-Concern,2.0
440790679,37768.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01068,amikacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01068,amikacin,0.0,No match,vNo-DILI-Concern,2.0
440790678,2141.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01067,amifostine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01067,amifostine,0.0,No match,vNo-DILI-Concern,1.0
440790677,2131.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01629,ambenonium,20250421,20210312,Curation Efforts|Governmental Organizations,LT01629,ambenonium,0.0,No match,vNo-DILI-Concern,2.0
440790676,5488548.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01215,Alvimopan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01215,alvimopan,0.0,No match,vNo-DILI-Concern,2.0
440790675,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01315,Alteplase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01315,alteplase,0.0,No match,vNo-DILI-Concern,2.0
440790674,123606.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01053,Almotriptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01053,almotriptan,0.0,No match,vNo-DILI-Concern,2.0
440790673,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01404,Alglucosidase alfa,20210312,20210312,Curation Efforts|Governmental Organizations,LT01404,alglucosidase alfa,0.0,No match,vNo-DILI-Concern,2.0
440790672,51263.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00925,ALFENTANIL,20250421,20210312,Curation Efforts|Governmental Organizations,LT00925,alfentanil,0.0,No match,vNo-DILI-Concern,2.0
440790671,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01364,Alemtuzumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01364,alemtuzumab,0.0,No match,vNo-DILI-Concern,2.0
440790670,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02385,Agalsidase beta,20210312,20210312,Curation Efforts|Governmental Organizations,LT02385,agalsidase beta,0.0,No match,vNo-DILI-Concern,2.0
440790669,60961.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01047,adenosine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01047,adenosine,0.0,No match,vNo-DILI-Concern,2.0
440790668,12035.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01041,acetylcysteine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01041,acetylcysteine,0.0,No match,vNo-DILI-Concern,2.0
440790667,6060.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02096,ACETYLCHOLINE CHLORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02096,acetylcholine chloride,0.0,No match,vNo-DILI-Concern,2.0
440790666,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01330,Abciximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01330,abciximab,0.0,No match,vNo-DILI-Concern,2.0
440790665,68740.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01088,Zoledronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01088,zoledronate,0.0,No match,vLess-DILI-Concern,2.0
440790664,14969.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00161,VANCOMYCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00161,vancomycin,0.0,No match,vLess-DILI-Concern,1.0
440790663,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01352,Trastuzumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01352,trastuzumab,0.0,No match,vLess-DILI-Concern,2.0
440790662,129211.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00982,TAMSULOSIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00982,tamsulosin,0.0,No match,vLess-DILI-Concern,1.0
440790661,5328.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01933,sulfamethizole,20250421,20210312,Curation Efforts|Governmental Organizations,LT01933,sulfamethizole,0.0,No match,vLess-DILI-Concern,2.0
440790660,5486971.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01154,Pregabalin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01154,pregabalin,0.0,No match,vLess-DILI-Concern,2.0
440790659,10158453.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00665,Prasugrel hydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT00665,prasugrel hydrochloride,0.0,No match,vLess-DILI-Concern,2.0
440790658,4771.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00805,phentermine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00805,phentermine,0.0,No match,vLess-DILI-Concern,1.0
440790657,5746.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00588,Mitomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00588,mitomycin,0.0,No match,vLess-DILI-Concern,1.0
440790656,4173.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00584,metronidazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00584,metronidazole,3.0,No match,vLess-DILI-Concern,1.0
440790655,4091.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00119,metformin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00119,metformin,0.0,No match,vLess-DILI-Concern,2.0
440790654,3821.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00859,ketamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00859,ketamine,0.0,No match,vLess-DILI-Concern,1.0
440790653,3038498.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00658,Fospropofol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00658,fospropofol,0.0,No match,vLess-DILI-Concern,2.0
440790652,3385.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01029,fluorouracil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01029,fluorouracil,0.0,No match,vLess-DILI-Concern,2.0
440790651,57363.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00167,finasteride,20210312,20210312,Curation Efforts|Governmental Organizations,LT00167,finasteride,0.0,No match,vLess-DILI-Concern,2.0
440790650,5281081.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01968,ENTACAPONE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01968,entacapone,0.0,No match,vLess-DILI-Concern,2.0
440790649,2973.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00386,deferoxamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00386,deferoxamine,0.0,No match,vLess-DILI-Concern,1.0
440790648,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01374,Darbepoetin alfa,20210312,20210312,Curation Efforts|Governmental Organizations,LT01374,darbepoetin alfa,0.0,No match,vLess-DILI-Concern,2.0
440790647,2710.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00066,chlorcyclizine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00066,chlorcyclizine,0.0,No match,vLess-DILI-Concern,2.0
440790646,7699.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00800,Benzonatate,20210804,20210312,Curation Efforts|Governmental Organizations,LT00800,benzonatate,0.0,No match,vLess-DILI-Concern,1.0
440790645,2244.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00053,aspirin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00053,aspirin,0.0,No match,vLess-DILI-Concern,2.0
440790644,139595263.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01373,Anakinra,20210312,20210312,Curation Efforts|Governmental Organizations,LT01373,anakinra,0.0,No match,vLess-DILI-Concern,2.0
440790643,3007.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02100,AMPHETAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02100,amphetamine,0.0,No match,vLess-DILI-Concern,2.0
440790642,5493444.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01244,Aliskiren,20231222,20210312,Curation Efforts|Governmental Organizations,LT01244,aliskiren,0.0,No match,vLess-DILI-Concern,2.0
440790641,2088.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00980,alendronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00980,alendronate,0.0,No match,vLess-DILI-Concern,1.0
440790640,71771.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01853,Aceclofenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT01853,aceclofenac,0.0,No match,vLess-DILI-Concern,2.0
440790639,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01402,Abatacept,20210312,20210312,Curation Efforts|Governmental Organizations,LT01402,abatacept,0.0,No match,vLess-DILI-Concern,2.0
440790638,5734.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00165,zonisamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00165,zonisamide,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790637,60854.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01017,Ziprasidone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01017,ziprasidone,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790636,54678486.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00647,warfarin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00647,warfarin,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790635,5978.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01862,vincristine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01862,vincristine,8.0,Adverse reactions,vLess-DILI-Concern,2.0
440790634,5656.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00174,venlafaxine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00174,venlafaxine,7.0,Adverse reactions,vLess-DILI-Concern,1.0
440790633,170361.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01242,Varenicline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01242,varenicline,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790632,60846.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01857,valsartan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01857,valsartan,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790631,135398742.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01856,Valaciclovir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01856,valaciclovir,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790630,25074470.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00460,Triptorelin pamoate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00460,triptorelin pamoate,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790629,5578.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01842,trimethoprim,20250421,20210312,Curation Efforts|Governmental Organizations,LT01842,trimethoprim,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790628,5546.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01833,triamterene,20231222,20210312,Curation Efforts|Governmental Organizations,LT01833,triamterene,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790627,5533.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01830,trazodone,20210804,20210312,Curation Efforts|Governmental Organizations,LT01830,trazodone,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790626,5530.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01829,tranylcypromine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01829,tranylcypromine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790625,5484727.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01828,trandolapril,20231222,20210312,Curation Efforts|Governmental Organizations,LT01828,trandolapril,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790624,5284627.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00455,topiramate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00455,topiramate,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790623,5509.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01820,tolmetin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01820,tolmetin,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790622,5503.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00266,tolazamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00266,tolazamide,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790621,5479.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00637,tinidazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00637,tinidazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790620,5452.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00451,thioridazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00451,thioridazine,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790619,5426.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00450,thalidomide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00450,thalidomide,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790618,5403.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00877,terbutaline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00877,terbutaline,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790617,5394.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00153,temozolomide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00153,temozolomide,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790616,65999.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02063,Telmisartan,20250421,20210312,Curation Efforts|Governmental Organizations,LT02063,telmisartan,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790615,445643.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00448,tacrolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT00448,tacrolimus,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790614,5215.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00146,sulfadiazine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00146,sulfadiazine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790613,5833.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00143,spironolactone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00143,spironolactone,2.0,Adverse reactions,vLess-DILI-Concern,1.0
440790612,4369359.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01251,Sitagliptin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01251,sitagliptin,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790611,21944094.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00443,Sirolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT00443,sirolimus,8.0,Adverse reactions,vLess-DILI-Concern,2.0
440790610,135398744.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01033,sildenafil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01033,sildenafil,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790609,5210.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00988,sibutramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00988,sibutramine,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790608,68617.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00625,sertraline,20210312,20210312,Curation Efforts|Governmental Organizations,LT00625,sertraline,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790607,5095.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00990,ropinirole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00990,ropinirole,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790606,77991.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01016,rivastigmine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01016,rivastigmine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790605,5073.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01735,risperidone,20210804,20210312,Curation Efforts|Governmental Organizations,LT01735,risperidone,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790604,135415564.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00139,RIFABUTIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT00139,rifabutin,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790603,65981.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01002,Repaglinide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01002,repaglinide,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790602,60815.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00987,REMIFENTANIL,20250421,20210312,Curation Efforts|Governmental Organizations,LT00987,remifentanil,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790601,3001055.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00138,ranitidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00138,ranitidine,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790600,5362129.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01726,ramipril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01726,ramipril,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790599,5029.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00264,rabeprazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00264,rabeprazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790598,441074.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01725,quinidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01725,quinidine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790597,54892.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01723,quinapril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01723,quinapril,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790596,10100.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00083,propoxyphene,20250421,20210312,Curation Efforts|Governmental Organizations,LT00083,propoxyphene,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790595,4943.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01708,propofol,20250421,20210312,Curation Efforts|Governmental Organizations,LT01708,propofol,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790594,4932.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01705,propafenone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01705,propafenone,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790593,4927.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00205,promethazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00205,promethazine,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790592,5994.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00192,progesterone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00192,progesterone,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790591,4917.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00437,prochlorperazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00437,prochlorperazine,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790590,4913.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01699,PROCAINAMIDE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01699,procainamide,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790589,5865.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00180,prednisone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00180,prednisone,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790588,5755.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00612,prednisolone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00612,prednisolone,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790587,3675.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01657,Phenelzine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01657,phenelzine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790586,5904.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01646,penicillin g,20231222,20210312,Curation Efforts|Governmental Organizations,LT01646,penicillin g,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790585,436058.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01322,Pegaspargase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01322,pegaspargase,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790584,43815.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00128,paroxetine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00128,paroxetine,8.0,Adverse reactions,vLess-DILI-Concern,1.0
440790583,4679.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00606,pantoprazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00606,pantoprazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790582,36314.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00430,paclitaxel,20210804,20210312,Curation Efforts|Governmental Organizations,LT00430,paclitaxel,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790581,4595.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01619,ondansetron,20210312,20210312,Curation Efforts|Governmental Organizations,LT01619,ondansetron,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790580,4594.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00206,omeprazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00206,omeprazole,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790579,22419.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00126,Olsalazine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00126,olsalazine,8.0,Adverse reactions,vLess-DILI-Concern,2.0
440790578,135398745.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00259,olanzapine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00259,olanzapine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790577,3033637.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00315,nizatidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00315,nizatidine,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790576,64143.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01012,nelfinavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01012,nelfinavir,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790575,3011155.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01233,Nelarabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01233,nelarabine,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790574,5281078.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01288,mycophenolate mofetil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01288,mycophenolate mofetil,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790573,152946.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02008,moxifloxacin,20210312,20210312,Curation Efforts|Governmental Organizations,LT02008,moxifloxacin,8.0,Adverse reactions,vLess-DILI-Concern,2.0
440790572,5281040.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02007,montelukast,20210312,20210312,Curation Efforts|Governmental Organizations,LT02007,montelukast,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790571,4171.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00309,metoprolol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00309,metoprolol,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790570,4168.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01549,metoclopramide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01549,metoclopramide,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790569,6741.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00478,methylprednisolone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00478,methylprednisolone,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790568,4158.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01545,methylphenidate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01545,methylphenidate,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790567,4100.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01532,methazolamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01532,methazolamide,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790566,15459.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00841,METAXALONE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00841,metaxalone,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790565,4075.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00414,Mesalazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00414,mesalazine,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790564,4054.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01908,memantine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01908,memantine,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790563,460612.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01517,melphalan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01517,melphalan,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790562,4046.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01514,mefloquine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01514,mefloquine,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790561,3961.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01499,losartan,20210804,20210312,Curation Efforts|Governmental Organizations,LT01499,losartan,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790560,5284585.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01497,loracarbef,20231222,20210312,Curation Efforts|Governmental Organizations,LT01497,loracarbef,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790559,5362119.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01492,lisinopril,20210804,20210312,Curation Efforts|Governmental Organizations,LT01492,lisinopril,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790558,441401.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01077,linezolid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01077,linezolid,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790557,5819.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01072,levothyroxine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01072,levothyroxine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790556,9955977.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00600,Levocetirizine dihydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT00600,levocetirizine dihydrochloride,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790555,5284583.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01059,Levetiracetam,20210312,20210312,Curation Efforts|Governmental Organizations,LT01059,levetiracetam,8.0,Adverse reactions,vLess-DILI-Concern,2.0
440790554,657181.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02019,leuprolide,20250421,20210312,Curation Efforts|Governmental Organizations,LT02019,leuprolide,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790553,3883.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00307,lansoprazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00307,lansoprazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790552,6321424.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00568,IVERMECTIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00568,ivermectin,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790551,3784.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01475,isradipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01475,isradipine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790550,60838.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01466,irinotecan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01466,irinotecan,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790549,3749.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01005,irbesartan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01005,irbesartan,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790548,3696.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00108,imipramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00108,imipramine,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790547,3690.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00562,ifosfamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00562,ifosfamide,4.0,Adverse reactions,vLess-DILI-Concern,1.0
440790546,3652.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02026,hydroxychloroquine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02026,hydroxychloroquine,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790545,3639.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01433,hydrochlorothiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01433,hydrochlorothiazide,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790544,3637.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00559,hydralazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00559,hydralazine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790543,772.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01426,Heparin sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT01426,heparin sodium,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790542,3559.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00405,haloperidol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00405,haloperidol,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790541,3478.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00243,glipizide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00243,glipizide,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790540,3476.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00173,glimepiride,20210804,20210312,Curation Efforts|Governmental Organizations,LT00173,glimepiride,7.0,Adverse reactions,vLess-DILI-Concern,1.0
440790539,3488.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00302,Glibenclamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00302,glibenclamide,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790538,55891.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01399,fosinopril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01399,fosinopril,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790537,446987.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01398,FOSFOMYCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01398,fosfomycin,6.0,Adverse reactions,vLess-DILI-Concern,2.0
440790536,636380.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01125,Fondaparinux sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT01125,fondaparinux sodium,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790535,3393.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01394,flurazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01394,flurazepam,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790534,3386.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00018,fluoxetine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00018,fluoxetine,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790533,3356.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01375,flecainide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01375,flecainide,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790532,3333.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00397,felodipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00397,felodipine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790531,3325.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00095,famotidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00095,famotidine,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790530,36462.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00094,etoposide,20210804,20210312,Curation Efforts|Governmental Organizations,LT00094,etoposide,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790529,5757.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00016,estradiol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00016,estradiol,2.0,Adverse reactions,vLess-DILI-Concern,1.0
440790528,9579578.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01589,Esomeprazole Sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT01589,esomeprazole Sodium,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790527,146570.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02929,Escitalopram,20210312,20210312,Curation Efforts|Governmental Organizations,LT02929,escitalopram,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790526,16667706.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00954,enoxaparin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00954,enoxaparin,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790525,5388962.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00296,enalapril,20231222,20210312,Curation Efforts|Governmental Organizations,LT00296,enalapril,7.0,Adverse reactions,vLess-DILI-Concern,1.0
440790524,54671203.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00393,doxycycline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00393,doxycycline,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790523,31703.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00335,doxorubicin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00335,doxorubicin,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790522,667477.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01314,doxepin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01314,doxepin,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790521,3152.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00052,donepezil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00052,donepezil,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790520,3114.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01302,disopyramide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01302,disopyramide,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790519,154101.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02909,Dexmethylphenidate,20250421,20210312,Curation Efforts|Governmental Organizations,LT02909,dexmethylphenidate,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790518,9578005.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01266,dexlansoprazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT01266,dexlansoprazole,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790517,125017.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00573,Desvenlafaxine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00573,desvenlafaxine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790516,124087.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01085,Desloratadine,20210804,20210312,Curation Efforts|Governmental Organizations,LT01085,desloratadine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790515,3062316.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01248,Dasatinib,20250421,20210312,Curation Efforts|Governmental Organizations,LT01248,dasatinib,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790514,16134395.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01200,DAPTOMYCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01200,daptomycin,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790513,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00961,Dalteparin sodium,20210312,20210312,Curation Efforts|Governmental Organizations,LT00961,dalteparin sodium,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790512,2913.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01255,CYPROHEPTADINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01255,cyproheptadine,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790511,2907.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00013,cyclophosphamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00013,cyclophosphamide,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790510,2895.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01249,cyclobenzaprine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01249,cyclobenzaprine,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790509,2882.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02004,Cromoglicate,20231222,20210312,Curation Efforts|Governmental Organizations,LT02004,cromoglicate,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790508,60606.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01023,clopidogrel,20210312,20210312,Curation Efforts|Governmental Organizations,LT01023,clopidogrel,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790507,2802.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00532,clonazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT00532,clonazepam,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790506,2771.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00219,citalopram,20210312,20210312,Curation Efforts|Governmental Organizations,LT00219,citalopram,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790505,2756.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01218,cimetidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01218,cimetidine,2.0,Adverse reactions,vLess-DILI-Concern,1.0
440790504,2727.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00379,chlorpropamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00379,chlorpropamide,2.0,Adverse reactions,vLess-DILI-Concern,1.0
440790503,2726.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00068,chlorpromazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00068,chlorpromazine,2.0,Adverse reactions,vLess-DILI-Concern,1.0
440790502,2720.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01208,chlorothiazide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01208,chlorothiazide,2.0,Adverse reactions,vLess-DILI-Concern,2.0
440790501,2719.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01207,chloroquine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01207,chloroquine,3.0,Adverse reactions,vLess-DILI-Concern,1.0
440790500,2712.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01198,chlordiazepoxide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01198,chlordiazepoxide,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790499,2678.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01190,cetirizine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01190,cetirizine,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790498,27447.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01189,cephalexin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01189,cephalexin,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790497,5479529.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01186,cefuroxime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01186,cefuroxime,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790496,5479530.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01185,ceftriaxone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01185,ceftriaxone,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790495,5481173.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00062,ceftazidime,20231222,20210312,Curation Efforts|Governmental Organizations,LT00062,ceftazidime,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790494,5281006.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01182,cefprozil,20250421,20210312,Curation Efforts|Governmental Organizations,LT01182,cefprozil,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790493,5742673.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01177,cefotaxime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01177,cefotaxime,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790492,44187.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01176,cefoperazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01176,cefoperazone,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790491,5479537.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01172,cefepime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01172,cefepime,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790490,6915944.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01289,cefdinir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01289,cefdinir,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790489,33255.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01171,cefazolin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01171,cefazolin,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790488,47965.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01167,cefadroxil,20250421,20210312,Curation Efforts|Governmental Organizations,LT01167,cefadroxil,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790487,51039.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01166,cefaclor,20231222,20210312,Curation Efforts|Governmental Organizations,LT01166,cefaclor,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790486,2585.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00207,carvedilol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00207,carvedilol,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790485,44093.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00059,captopril,20210312,20210312,Curation Efforts|Governmental Organizations,LT00059,captopril,7.0,Adverse reactions,vLess-DILI-Concern,1.0
440790484,2541.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01022,candesartan,20210804,20210312,Curation Efforts|Governmental Organizations,LT01022,candesartan,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790483,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02432,Canakinumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT02432,canakinumab,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790482,444.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00058,bupropion,20210312,20210312,Curation Efforts|Governmental Organizations,LT00058,bupropion,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790481,2315.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00825,BENDROFLUMETHIAZIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00825,bendroflumethiazide,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790480,5362124.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01116,benazepril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01116,benazepril,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790479,2284.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01113,baclofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT01113,baclofen,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790478,447043.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00265,azithromycin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00265,azithromycin,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790477,2249.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00277,atenolol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00277,atenolol,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790476,2187.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00263,anastrozole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00263,anastrozole,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790475,33613.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00507,amoxicillin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00507,amoxicillin,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790474,2162.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00175,amlodipine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00175,amlodipine,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790473,2160.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00047,amitriptyline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00047,amitriptyline,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790472,16231.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02070,AMILORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02070,amiloride,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790471,2118.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00501,alprazolam,20250421,20210312,Curation Efforts|Governmental Organizations,LT00501,alprazolam,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790470,2099.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01070,alosetron,20210312,20210312,Curation Efforts|Governmental Organizations,LT01070,alosetron,4.0,Adverse reactions,vLess-DILI-Concern,2.0
440790469,2092.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01107,alfuzosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01107,alfuzosin,5.0,Adverse reactions,vLess-DILI-Concern,2.0
440790468,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01387,Adalimumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01387,adalimumab,7.0,Adverse reactions,vLess-DILI-Concern,2.0
440790467,135398513.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00041,Aciclovir,20210312,20210312,Curation Efforts|Governmental Organizations,LT00041,aciclovir,5.0,Adverse reactions,vLess-DILI-Concern,1.0
440790466,1978.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01035,acebutolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01035,acebutolol,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790465,71158.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01141,Acamprosate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01141,acamprosate,3.0,Adverse reactions,vLess-DILI-Concern,2.0
440790464,445354.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00162,Vitamin A,20231222,20210312,Curation Efforts|Governmental Organizations,LT00162,vitamin a,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790463,2520.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00332,VERAPAMIL,20210312,20210312,Curation Efforts|Governmental Organizations,LT00332,verapamil,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790462,119607.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01971,Valdecoxib,20250421,20210312,Curation Efforts|Governmental Organizations,LT01971,valdecoxib,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790461,5453.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01804,thiotepa,20250421,20210312,Curation Efforts|Governmental Organizations,LT01804,thiotepa,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790460,2723601.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00452,thioguanine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00452,thioguanine,2.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790459,54675776.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00036,tetracycline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00036,tetracycline,2.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790458,464205.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02224,Tenofovir,20231222,20210312,Curation Efforts|Governmental Organizations,LT02224,tenofovir,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790457,452548.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01786,teniposide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01786,teniposide,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790456,2724354.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01766,Succimer,20250421,20210312,Curation Efforts|Governmental Organizations,LT01766,succimer,2.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790455,54454.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00142,simvastatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00142,simvastatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790454,441243.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01746,SAQUINAVIR,20210312,20210312,Curation Efforts|Governmental Organizations,LT01746,saquinavir,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790453,5161.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01684,Salsalate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01684,salsalate,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790452,446157.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01928,Rosuvastatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01928,rosuvastatin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790451,77999.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00140,rosiglitazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00140,rosiglitazone,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790450,3034034.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01923,Quinine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01923,quinine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790449,5002.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00267,quetiapine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00267,quetiapine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790448,4993.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01716,pyrimethamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01716,pyrimethamine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790447,1046.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00166,pyrazinamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00166,pyrazinamide,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790446,4915.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00614,procarbazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00614,procarbazine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790445,54687.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00186,pravastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00186,pravastatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790444,54676228.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01679,piroxicam,20210312,20210312,Curation Efforts|Governmental Organizations,LT01679,piroxicam,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790443,4829.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00134,Pioglitazone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00134,pioglitazone,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790442,4763.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00030,phenobarbital,20250421,20210312,Curation Efforts|Governmental Organizations,LT00030,phenobarbital,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790441,4748.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01655,perphenazine,20210804,20210312,Curation Efforts|Governmental Organizations,LT01655,perphenazine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790440,4735.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00129,pentamidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00129,pentamidine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790439,5852.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00488,penicillamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00488,penicillamine,2.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790438,34312.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01056,OXCARBAZEPINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01056,oxcarbazepine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790437,4614.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00429,oxaprozin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00429,oxaprozin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790436,6196.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01624,oxacillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01624,oxacillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790435,4583.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01620,ofloxacin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01620,ofloxacin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790434,383414.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01618,Octreotide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01618,octreotide,2.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790433,4539.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01614,norfloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01614,norfloxacin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790432,4485.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00313,nifedipine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00313,nifedipine,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790431,156391.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00593,NAPROXEN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00593,naproxen,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790430,8982.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01583,nafcillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01583,nafcillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790429,4236.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00589,modafinil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00589,modafinil,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790428,4212.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01565,mitoxantrone,20250421,20210312,Curation Efforts|Governmental Organizations,LT01565,mitoxantrone,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790427,4205.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01560,mirtazapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01560,mirtazapine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790426,6010.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00222,methyltestosterone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00222,methyltestosterone,2.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790425,4114.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01537,methoxsalen,20231222,20210312,Curation Efforts|Governmental Organizations,LT01537,methoxsalen,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790424,441130.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01525,meropenem,20210312,20210312,Curation Efforts|Governmental Organizations,LT01525,meropenem,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790423,54677470.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00117,meloxicam,20210312,20210312,Curation Efforts|Governmental Organizations,LT00117,meloxicam,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790422,4030.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00308,mebendazole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00308,mebendazole,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790421,53232.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00576,lovastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00576,lovastatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790420,3950.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00575,lomustine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00575,lomustine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790419,3902.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00572,letrozole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00572,letrozole,2.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790418,216326.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01238,Lenalidomide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01238,lenalidomide,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790417,60825.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00569,lamivudine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00569,lamivudine,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790416,3826.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00204,ketorolac,20250421,20210312,Curation Efforts|Governmental Organizations,LT00204,ketorolac,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790415,3825.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00023,ketoprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00023,ketoprofen,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790414,3672.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00199,ibuprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00199,ibuprofen,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790413,9571107.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01084,Gemifloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01084,gemifloxacin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790412,3446.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00300,gabapentin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00300,gabapentin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790411,446155.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00172,fluvastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00172,fluvastatin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790410,3339.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00098,fenofibrate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00098,fenofibrate,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790409,150311.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01153,Ezetimibe,20250421,20210312,Curation Efforts|Governmental Organizations,LT01153,ezetimibe,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790408,2761171.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01348,ethionamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01348,ethionamide,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790407,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01353,Etanercept,20210312,20210312,Curation Efforts|Governmental Organizations,LT01353,etanercept,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790406,148124.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01309,docetaxel,20250421,20210312,Curation Efforts|Governmental Organizations,LT01309,docetaxel,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790405,18381.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02041,dicloxacillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02041,dicloxacillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790404,2955.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00289,dapsone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00289,dapsone,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790403,6098.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01235,cloxacillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01235,cloxacillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790402,2812.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00248,clotrimazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00248,clotrimazole,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790401,1548953.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00233,clomiphene,20231222,20210312,Curation Efforts|Governmental Organizations,LT00233,clomiphene,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790400,2796.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00011,clofibrate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00011,clofibrate,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790399,446598.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01225,clindamycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01225,clindamycin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790398,441203.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00071,cisplatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00071,cisplatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790397,2708.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00286,chlorambucil,20250421,20210312,Curation Efforts|Governmental Organizations,LT00286,chlorambucil,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790396,2662.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00252,celecoxib,20250421,20210312,Curation Efforts|Governmental Organizations,LT00252,celecoxib,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790395,426756.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00061,carboplatin,20250421,20210312,Curation Efforts|Governmental Organizations,LT00061,carboplatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0
440790394,20824.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01159,carbenicillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01159,carbenicillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790393,31101.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00279,bromocriptine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00279,bromocriptine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790392,6918453.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02166,AURANOFIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT02166,auranofin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790391,148192.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01199,Atazanavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01199,atazanavir,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790390,6249.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00049,ampicillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00049,ampicillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790389,14956.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00048,amphotericin b,20231222,20210312,Curation Efforts|Governmental Organizations,LT00048,amphotericin b,3.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790388,60172.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01155,ADEFOVIR,20231222,20210312,Curation Efforts|Governmental Organizations,LT01155,adefovir,2.0,Warnings and precautions,vLess-DILI-Concern,2.0
440790387,60490.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00649,ZILEUTON,20210312,20210312,Curation Efforts|Governmental Organizations,LT00649,zileuton,5.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790386,5717.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01869,zafirlukast,20210312,20210312,Curation Efforts|Governmental Organizations,LT01869,zafirlukast,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790385,71616.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01097,Voriconazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT01097,voriconazole,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790384,216237.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00661,Tolvaptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00661,tolvaptan,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790383,5487.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00155,tizanidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00155,tizanidine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790382,5472.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00227,ticlopidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00227,ticlopidine,4.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790381,5430.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00635,thiabendazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00635,thiabendazole,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790380,6013.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00223,testosterone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00223,testosterone,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790379,1549008.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00634,terbinafine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00634,terbinafine,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790378,3002190.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01944,Telithromycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01944,telithromycin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790377,2733526.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00152,tamoxifen,20250421,20210312,Curation Efforts|Governmental Organizations,LT00152,tamoxifen,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790376,1548887.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00148,sulindac,20210312,20210312,Curation Efforts|Governmental Organizations,LT00148,sulindac,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790375,5339.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00147,sulfasalazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00147,sulfasalazine,5.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790374,216239.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01241,Sorafenib,20250421,20210312,Curation Efforts|Governmental Organizations,LT01241,sorafenib,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790373,392622.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01737,ritonavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01737,ritonavir,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790372,5070.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01731,riluzole,20210312,20210312,Curation Efforts|Governmental Organizations,LT01731,riluzole,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790371,135398735.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00034,rifampin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00034,rifampin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790370,54671008.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00642,Raltegravir,20210312,20210312,Curation Efforts|Governmental Organizations,LT00642,raltegravir,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790369,1775.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00032,phenytoin,20210804,20210312,Curation Efforts|Governmental Organizations,LT00032,phenytoin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790368,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01367,Peginterferon alfa-2b,20210312,20210312,Curation Efforts|Governmental Organizations,LT01367,peginterferon alfa-2b,4.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790367,4680.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01637,papaverine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01637,papaverine,5.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790366,9887054.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01181,oxaliplatin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01181,oxaliplatin,4.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790365,3034010.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02216,orlistat,20210312,20210312,Curation Efforts|Governmental Organizations,LT02216,orlistat,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790364,4543.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01615,nortriptyline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01615,nortriptyline,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790363,6604200.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00125,nitrofurantoin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00125,nitrofurantoin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790362,4493.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01600,nilutamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01600,nilutamide,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790361,938.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00312,niacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00312,niacin,7.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790360,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01393,Natalizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01393,natalizumab,5.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790359,9677.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02121,NANDROLONE DECANOATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02121,nandrolone decanoate,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790358,54675783.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00416,minocycline,20210312,20210312,Curation Efforts|Governmental Organizations,LT00416,minocycline,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790357,65833.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01263,Milnacipran,20210312,20210312,Curation Efforts|Governmental Organizations,LT01263,milnacipran,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790356,477468.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01187,Micafungin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01187,micafungin,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790355,38853.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00121,methyldopa,20231222,20210312,Curation Efforts|Governmental Organizations,LT00121,methyldopa,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790354,1349907.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00580,methimazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00580,methimazole,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790353,667490.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00003,mercaptopurine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00003,mercaptopurine,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790352,4044.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00116,mefenamic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT00116,mefenamic acid,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790351,149096.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01488,LEVOFLOXACIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT01488,levofloxacin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790350,3878.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01481,lamotrigine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01481,lamotrigine,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790349,3869.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00112,labetalol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00112,labetalol,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790348,55283.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00182,itraconazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00182,itraconazole,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790347,5282379.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00234,Isotretinoin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00234,isotretinoin,5.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790346,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01328,Interferon beta-1b,20210312,20210312,Curation Efforts|Governmental Organizations,LT01328,interferon beta-1b,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790345,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01332,Interferon beta-1a,20210312,20210312,Curation Efforts|Governmental Organizations,LT01332,interferon beta-1a,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790344,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01336,Interferon alfacon-1,20210312,20210312,Curation Efforts|Governmental Organizations,LT01336,interferon alfacon-1,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790343,71306834.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01306,INTERFERON ALFA-2B,20250421,20210312,Curation Efforts|Governmental Organizations,LT01306,interferon alfa-2b,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790342,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01311,INTERFERON ALFA-2A,20210312,20210312,Curation Efforts|Governmental Organizations,,,,,,
440790341,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01350,Infliximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01350,infliximab,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790340,3715.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00022,indomethacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00022,indomethacin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790339,5291.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00107,Imatinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00107,imatinib,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790338,3657.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00106,hydroxyurea,20231222,20210312,Curation Efforts|Governmental Organizations,LT00106,hydroxyurea,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790337,441140.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00558,griseofulvin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00558,griseofulvin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790336,3463.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00020,gemfibrozil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00020,gemfibrozil,4.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790335,60750.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01407,gemcitabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01407,gemcitabine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790334,123631.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00402,Gefitinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00402,gefitinib,4.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790333,56339.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01400,Fosphenytoin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01400,fosphenytoin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790332,3365.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00179,fluconazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00179,fluconazole,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790331,3342.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00099,fenoprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00099,fenoprofen,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790330,134018.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00554,Febuxostat,20231222,20210312,Curation Efforts|Governmental Organizations,LT00554,febuxostat,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790329,60198.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00394,EXEMESTANE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00394,exemestane,4.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790328,193962.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00653,Etravirine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00653,etravirine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790327,3308.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00240,etodolac,20210312,20210312,Curation Efforts|Governmental Organizations,LT00240,etodolac,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790326,3279.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01345,ethambutol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01345,ethambutol,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790325,259331.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01342,estramustine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01342,estramustine,4.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790324,12560.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00092,erythromycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00092,erythromycin,5.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790323,176870.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01214,Erlotinib,20210312,20210312,Curation Efforts|Governmental Organizations,LT01214,erlotinib,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790322,64139.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01323,efavirenz,20210312,20210312,Curation Efforts|Governmental Organizations,LT01323,efavirenz,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790321,60835.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02035,duloxetine,20210312,20210312,Curation Efforts|Governmental Organizations,LT02035,duloxetine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790320,208898.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00671,Dronedarone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00671,dronedarone,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790319,3117.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00295,disulfiram,20250421,20210312,Curation Efforts|Governmental Organizations,LT00295,disulfiram,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790318,39186.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01292,diltiazem,20250421,20210312,Curation Efforts|Governmental Organizations,LT01292,diltiazem,4.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790317,3059.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00085,diflunisal,20210312,20210312,Curation Efforts|Governmental Organizations,LT00085,diflunisal,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790316,135398739.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01285,didanosine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01285,didanosine,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790315,3033.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00084,diclofenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT00084,diclofenac,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790314,213039.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01243,Darunavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01243,darunavir,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790313,457193.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00079,DACTINOMYCIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT00079,dactinomycin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790312,5284373.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00380,cyclosporine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00380,cyclosporine,7.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790311,135398737.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00287,clozapine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00287,clozapine,5.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790310,2801.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00185,clomipramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00185,clomipramine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790309,84029.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00187,clarithromycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00187,clarithromycin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790308,2764.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00178,ciprofloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00178,ciprofloxacin,7.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790307,2733.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00067,chlorzoxazone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00067,chlorzoxazone,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790306,2554.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00060,carbamazepine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00060,carbamazepine,7.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790305,2478.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00280,busulfan,20210312,20210312,Curation Efforts|Governmental Organizations,LT00280,busulfan,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790304,387447.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01202,Bortezomib,20231222,20210312,Curation Efforts|Governmental Organizations,LT01202,bortezomib,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790303,2375.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00056,bicalutamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00056,bicalutamide,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790302,82146.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01064,Bexarotene,20210312,20210312,Curation Efforts|Governmental Organizations,LT01064,bexarotene,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790301,2265.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00006,azathioprine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00006,azathioprine,5.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790300,60823.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00258,atorvastatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00258,atorvastatin,5.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790299,54841.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01139,Atomoxetine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01139,atomoxetine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790298,5460875.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01303,Asparaginase,20250421,20210312,Curation Efforts|Governmental Organizations,LT01303,asparaginase,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790297,135401907.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00043,allopurinol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00043,allopurinol,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790296,2082.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00499,albendazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00499,albendazole,7.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790295,1986.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00498,acetazolamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00498,acetazolamide,8.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790294,1983.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00004,acetaminophen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00004,acetaminophen,5.0,Warnings and precautions,vMost-DILI-Concern,2.0
440790293,41774.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01034,acarbose,20210312,20210312,Curation Efforts|Governmental Organizations,LT01034,acarbose,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790292,441300.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00040,abacavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT00040,abacavir,8.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790291,4649.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00505,4-Aminosalicylic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00505,4-aminosalicylic acid,5.0,Warnings and precautions,vMost-DILI-Concern,1.0
440790290,54682461.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01220,Tipranavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01220,tipranavir,8.0,Box warning,vMost-DILI-Concern,1.0
440790289,3002977.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00640,Maraviroc,20250421,20210312,Curation Efforts|Governmental Organizations,LT00640,maraviroc,3.0,Box warning,vMost-DILI-Concern,1.0
440790288,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00477,Gemtuzumab ozogamicin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00477,gemtuzumab ozogamicin,8.0,Box warning,vMost-DILI-Concern,1.0
440790287,135449331.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00663,Eltrombopag olamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00663,eltrombopag olamine,4.0,Box warning,vMost-DILI-Concern,1.0
440790286,23663956.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00684,DIVALPROEX SODIUM,20231222,20210312,Curation Efforts|Governmental Organizations,LT00684,divalproex sodium,8.0,Box warning,vMost-DILI-Concern,2.0
440790285,35370.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00163,zidovudine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00163,zidovudine,8.0,Box warning,vMost-DILI-Concern,1.0
440790284,3121.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00160,VALPROIC ACID,20231222,20210312,Curation Efforts|Governmental Organizations,LT00160,valproic acid,8.0,Box warning,vMost-DILI-Concern,1.0
440790283,4659569.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00156,Tolcapone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00156,tolcapone,8.0,Box warning,vMost-DILI-Concern,1.0
440790282,5329102.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00565,Sunitinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00565,sunitinib,8.0,Box warning,vMost-DILI-Concern,1.0
440790281,18283.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00144,stavudine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00144,stavudine,8.0,Box warning,vMost-DILI-Concern,1.0
440790280,657298.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00136,propylthiouracil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00136,propylthiouracil,8.0,Box warning,vMost-DILI-Concern,1.0
440790279,439693.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01651,pentostatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01651,pentostatin,3.0,Box warning,vMost-DILI-Concern,2.0
440790278,10113978.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00672,Pazopanib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00672,pazopanib,8.0,Box warning,vMost-DILI-Concern,1.0
440790277,5281034.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00235,oxymetholone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00235,oxymetholone,7.0,Box warning,vMost-DILI-Concern,1.0
440790276,5878.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00845,OXANDROLONE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00845,oxandrolone,8.0,Box warning,vMost-DILI-Concern,1.0
440790275,4463.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00260,nevirapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00260,nevirapine,8.0,Box warning,vMost-DILI-Concern,1.0
440790274,4449.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00124,nefazodone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00124,nefazodone,8.0,Box warning,vMost-DILI-Concern,1.0
440790273,4178.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01553,Mexiletine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01553,mexiletine,3.0,Box warning,vMost-DILI-Concern,1.0
440790272,126941.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00026,methotrexate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00026,methotrexate,3.0,Box warning,vMost-DILI-Concern,1.0
440790271,3899.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00113,leflunomide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00113,leflunomide,8.0,Box warning,vMost-DILI-Concern,1.0
440790270,208908.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02204,Lapatinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT02204,lapatinib,8.0,Box warning,vMost-DILI-Concern,1.0
440790269,3823.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00111,ketoconazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00111,ketoconazole,8.0,Box warning,vMost-DILI-Concern,1.0
440790268,3767.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00306,isoniazid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00306,isoniazid,8.0,Box warning,vMost-DILI-Concern,1.0
440790267,3397.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00101,flutamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00101,flutamide,8.0,Box warning,vMost-DILI-Concern,1.0
440790266,3331.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00097,felbamate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00097,felbamate,7.0,Box warning,vMost-DILI-Concern,1.0
440790265,214348.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00563,Deferasirox,20210312,20210312,Curation Efforts|Governmental Organizations,LT00563,deferasirox,7.0,Box warning,vMost-DILI-Concern,1.0
440790264,6914273.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00080,dantrolene,20250421,20210312,Curation Efforts|Governmental Organizations,LT00080,dantrolene,8.0,Box warning,vMost-DILI-Concern,1.0
440790263,28417.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00539,danazol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00539,danazol,8.0,Box warning,vMost-DILI-Concern,1.0
440790262,2942.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00288,dacarbazine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00288,dacarbazine,6.0,Box warning,vMost-DILI-Concern,1.0
440790261,6253.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00209,cytarabine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00209,cytarabine,3.0,Box warning,vMost-DILI-Concern,1.0
440790260,104865.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01140,Bosentan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01140,bosentan,7.0,Box warning,vMost-DILI-Concern,1.0
440790259,2157.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00046,amiodarone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00046,amiodarone,8.0,Box warning,vMost-DILI-Concern,1.0
440790258,5284513.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01042,Acitretin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01042,acitretin,5.0,Box warning,vMost-DILI-Concern,1.0
440790257,60919.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00687,TASOSARTAN,20210312,20210312,Curation Efforts|Governmental Organizations,LT00687,tasosartan,8.0,Discontinued,vMost-DILI-Concern,1.0
440790256,153270.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00698,Pralnacasan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00698,pralnacasan,8.0,Discontinued,vMost-DILI-Concern,1.0
440790255,5480200.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00702,Pafuramidine,20250421,20210312,Curation Efforts|Governmental Organizations,,,,,,
440790254,172307.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00701,Fiduxosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00701,fiduxosin,8.0,Discontinued,vMost-DILI-Concern,1.0
440790253,50313.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01371,FIALURIDINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01371,fialuridine,8.0,Discontinued,vMost-DILI-Concern,1.0
440790252,6918508.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01870,Falnidamol,20210804,20210312,Curation Efforts|Governmental Organizations,LT01870,falnidamol,8.0,Discontinued,vMost-DILI-Concern,1.0
440790251,32756.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00695,Dermatan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00695,dermatan,8.0,Discontinued,vMost-DILI-Concern,1.0
440790250,3001322.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00693,aplaviroc,20231222,20210312,Curation Efforts|Governmental Organizations,LT00693,aplaviroc,8.0,Discontinued,vMost-DILI-Concern,1.0
440790249,5365247.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01874,Zimelidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01874,zimelidine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790248,9574101.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02033,Ximelagatran,20250421,20210312,Curation Efforts|Governmental Organizations,LT02033,ximelagatran,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790247,239062.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01867,Xenazoic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT01867,xenazoic acid,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790246,29321.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00700,Triacetyldiphenolisatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00700,triacetyldiphenolisatin,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790245,53359.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01822,TOLRESTAT,20231222,20210312,Curation Efforts|Governmental Organizations,LT01822,tolrestat,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790244,65592.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00691,Tilbroquinol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00691,tilbroquinol,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790243,38409.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00636,Ticrynafen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00636,ticrynafen,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790242,5340.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00632,sulfathiazole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00632,sulfathiazole,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790241,11033.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00699,Sulfacarbamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00699,sulfacarbamide,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790240,5354.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01816,sulcotidil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01816,sulcotidil,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790239,216235.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02449,Sitaxsentan,20231222,20210312,Curation Efforts|Governmental Organizations,LT02449,sitaxsentan,8.0,Withdrawn,vMost-DILI-Concern,2.0
440790238,35935.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01680,Pirprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT01680,pirprofen,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790237,6761.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00697,PIPAMAZINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00697,pipamazine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790236,71467.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00703,Phenoxypropazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00703,phenoxypropazine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790235,4746.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00131,PERHEXILINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00131,perhexiline,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790234,4723.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00246,pemoline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00246,pemoline,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790233,31315.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00690,Oxyphenisatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00690,oxyphenisatin,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790232,4528.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01611,Nomifensine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01611,nomifensine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790231,71900.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01854,Nitrefazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT01854,nitrefazole,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790230,3033952.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01602,Niperotidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01602,niperotidine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790229,4472.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01594,Nialamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01594,nialamide,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790228,4260.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01574,Moxisylyte,20231222,20210312,Curation Efforts|Governmental Organizations,LT01574,moxisylyte,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790227,6075.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02110,MEPAZINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02110,mepazine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790226,6179.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01508,Mebanazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01508,mebanazine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790225,151166.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00686,Lumiracoxib,20210312,20210312,Curation Efforts|Governmental Organizations,LT00686,lumiracoxib,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790224,71169.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00696,Isaxonine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00696,isaxonine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790223,3748.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00109,iproniazid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00109,iproniazid,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790222,15250.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00560,Ibufenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT00560,ibufenac,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790221,3474.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02092,glafenine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02092,glafenine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790220,3351.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01372,fipexide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01372,fipexide,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790219,28858.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01846,Fenclozic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01846,fenclozic acid,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790218,40399.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01359,EXIFONE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01359,exifone,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790217,2898.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01250,cyclofenil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01250,cyclofenil,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790216,33176.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01228,Clometacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01228,clometacin,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790215,21382.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00694,Clomacran,20231222,20210312,Curation Efforts|Governmental Organizations,LT00694,clomacran,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790214,8593.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01219,Cinchophen,20210804,20210312,Curation Efforts|Governmental Organizations,LT01219,cinchophen,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790213,60726.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00519,Bromfenac,20250421,20210312,Curation Efforts|Governmental Organizations,LT00519,bromfenac,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790212,6237.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01121,BENZIODARONE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01121,benziodarone,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790211,2333.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00278,benzbromarone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00278,benzbromarone,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790210,255968.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01120,Benzarone,20250421,20210312,Curation Efforts|Governmental Organizations,LT01120,benzarone,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790209,39941.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00513,Benoxaprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00513,benoxaprofen,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790208,2313.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01117,bendazac,20231222,20210312,Curation Efforts|Governmental Organizations,LT01117,bendazac,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790207,54897.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01060,ALPIDEM,20210804,20210312,Curation Efforts|Governmental Organizations,LT01060,alpidem,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790206,30951.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00692,alclofenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT00692,alclofenac,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790205,5282517.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00461,Alatrofloxacin mesylate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00461,alatrofloxacin mesylate,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790204,2081.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02213,Alaproclate,20231222,20210312,Curation Efforts|Governmental Organizations,LT02213,alaproclate,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790203,62959.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00645,Trovafloxacin,20210804,20210312,Curation Efforts|Governmental Organizations,LT00645,trovafloxacin,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790202,5591.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00168,troglitazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00168,troglitazone,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790201,57394584.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01858,Tetrabamate,20250421,20210312,Curation Efforts|Governmental Organizations,LT01858,tetrabamate,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790200,4495.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00314,nimesulide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00314,nimesulide,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790199,65869.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01849,Ebrotidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01849,ebrotidine,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790198,65679.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01318,Droxicam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01318,droxicam,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790197,2717.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01201,chlormezanone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01201,chlormezanone,8.0,Withdrawn,vMost-DILI-Concern,1.0
440790196,34870.0,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00045,Amineptine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00045,amineptine,8.0,Withdrawn,vMost-DILI-Concern,1.0
